Project
Illumina Body Map 2
Navigation
Downloads
Results for RARG
Z-value: 1.72
Motif logo
Transcription factors associated with RARG
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
RARG
|
ENSG00000172819.12 | retinoic acid receptor gamma |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| RARG | hg19_v2_chr12_-_53614043_53614154 | -0.23 | 2.0e-01 | Click! |
Activity profile of RARG motif
Sorted Z-values of RARG motif
| Promoter | Log-likelihood | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr1_+_160097462 | 7.38 |
ENST00000447527.1
|
ATP1A2
|
ATPase, Na+/K+ transporting, alpha 2 polypeptide |
| chr11_-_111784005 | 6.66 |
ENST00000527899.1
|
CRYAB
|
crystallin, alpha B |
| chr17_-_53809473 | 6.59 |
ENST00000575734.1
|
TMEM100
|
transmembrane protein 100 |
| chr2_+_69240415 | 5.69 |
ENST00000409829.3
|
ANTXR1
|
anthrax toxin receptor 1 |
| chr2_+_69240302 | 5.57 |
ENST00000303714.4
|
ANTXR1
|
anthrax toxin receptor 1 |
| chr3_-_50340996 | 5.26 |
ENST00000266031.4
ENST00000395143.2 ENST00000457214.2 ENST00000447605.2 ENST00000418723.1 ENST00000395144.2 |
HYAL1
|
hyaluronoglucosaminidase 1 |
| chr4_-_186696425 | 5.05 |
ENST00000430503.1
ENST00000319454.6 ENST00000450341.1 |
SORBS2
|
sorbin and SH3 domain containing 2 |
| chr7_-_107642348 | 4.98 |
ENST00000393561.1
|
LAMB1
|
laminin, beta 1 |
| chr3_-_58613323 | 4.95 |
ENST00000474531.1
ENST00000465970.1 |
FAM107A
|
family with sequence similarity 107, member A |
| chr12_-_91576429 | 4.80 |
ENST00000552145.1
ENST00000546745.1 |
DCN
|
decorin |
| chr12_-_16760021 | 4.74 |
ENST00000540445.1
|
LMO3
|
LIM domain only 3 (rhombotin-like 2) |
| chr11_-_111783595 | 4.71 |
ENST00000528628.1
|
CRYAB
|
crystallin, alpha B |
| chr2_+_69240511 | 4.44 |
ENST00000409349.3
|
ANTXR1
|
anthrax toxin receptor 1 |
| chr16_-_4292071 | 4.38 |
ENST00000399609.3
|
SRL
|
sarcalumenin |
| chr12_-_16759711 | 4.29 |
ENST00000447609.1
|
LMO3
|
LIM domain only 3 (rhombotin-like 2) |
| chr9_-_33402506 | 4.22 |
ENST00000377425.4
ENST00000537089.1 ENST00000297988.1 ENST00000539936.1 ENST00000541274.1 |
AQP7
|
aquaporin 7 |
| chr1_-_156647189 | 4.19 |
ENST00000368223.3
|
NES
|
nestin |
| chr14_-_21492251 | 4.10 |
ENST00000554398.1
|
NDRG2
|
NDRG family member 2 |
| chr5_+_145316120 | 4.04 |
ENST00000359120.4
|
SH3RF2
|
SH3 domain containing ring finger 2 |
| chr12_-_16760195 | 4.00 |
ENST00000546281.1
ENST00000537757.1 |
LMO3
|
LIM domain only 3 (rhombotin-like 2) |
| chr20_+_43343886 | 3.77 |
ENST00000190983.4
|
WISP2
|
WNT1 inducible signaling pathway protein 2 |
| chr22_+_31518938 | 3.73 |
ENST00000412985.1
ENST00000331075.5 ENST00000412277.2 ENST00000420017.1 ENST00000400294.2 ENST00000405300.1 ENST00000404390.3 |
INPP5J
|
inositol polyphosphate-5-phosphatase J |
| chr15_-_75017711 | 3.69 |
ENST00000567032.1
ENST00000564596.1 ENST00000566503.1 ENST00000395049.4 ENST00000395048.2 ENST00000379727.3 |
CYP1A1
|
cytochrome P450, family 1, subfamily A, polypeptide 1 |
| chr19_-_4517613 | 3.68 |
ENST00000301286.3
|
PLIN4
|
perilipin 4 |
| chr11_-_111783919 | 3.62 |
ENST00000531198.1
ENST00000533879.1 |
CRYAB
|
crystallin, alpha B |
| chr1_-_917466 | 3.62 |
ENST00000341290.2
|
C1orf170
|
chromosome 1 open reading frame 170 |
| chr20_-_62130474 | 3.61 |
ENST00000217182.3
|
EEF1A2
|
eukaryotic translation elongation factor 1 alpha 2 |
| chr6_+_53976211 | 3.55 |
ENST00000503951.1
|
MLIP
|
muscular LMNA-interacting protein |
| chr11_-_2160180 | 3.54 |
ENST00000381406.4
|
IGF2
|
insulin-like growth factor 2 (somatomedin A) |
| chr14_-_21492113 | 3.47 |
ENST00000554094.1
|
NDRG2
|
NDRG family member 2 |
| chr4_-_186696561 | 3.47 |
ENST00000445115.1
ENST00000451701.1 ENST00000457247.1 ENST00000435480.1 ENST00000425679.1 ENST00000457934.1 |
SORBS2
|
sorbin and SH3 domain containing 2 |
| chr19_+_35629702 | 3.46 |
ENST00000351325.4
|
FXYD1
|
FXYD domain containing ion transport regulator 1 |
| chr19_-_49658641 | 3.46 |
ENST00000252825.4
|
HRC
|
histidine rich calcium binding protein |
| chr5_+_149569520 | 3.44 |
ENST00000230671.2
ENST00000524041.1 |
SLC6A7
|
solute carrier family 6 (neurotransmitter transporter), member 7 |
| chr2_+_18059906 | 3.44 |
ENST00000304101.4
|
KCNS3
|
potassium voltage-gated channel, delayed-rectifier, subfamily S, member 3 |
| chr20_-_42816206 | 3.40 |
ENST00000372980.3
|
JPH2
|
junctophilin 2 |
| chr9_-_130637244 | 3.37 |
ENST00000373156.1
|
AK1
|
adenylate kinase 1 |
| chrX_+_70521584 | 3.33 |
ENST00000373829.3
ENST00000538820.1 |
ITGB1BP2
|
integrin beta 1 binding protein (melusin) 2 |
| chr3_+_112930306 | 3.29 |
ENST00000495514.1
|
BOC
|
BOC cell adhesion associated, oncogene regulated |
| chr12_-_56106060 | 3.26 |
ENST00000452168.2
|
ITGA7
|
integrin, alpha 7 |
| chr1_+_22970119 | 3.26 |
ENST00000374640.4
ENST00000374639.3 ENST00000374637.1 |
C1QC
|
complement component 1, q subcomponent, C chain |
| chr4_-_186696515 | 3.25 |
ENST00000456596.1
ENST00000414724.1 |
SORBS2
|
sorbin and SH3 domain containing 2 |
| chr6_+_53976235 | 3.24 |
ENST00000502396.1
ENST00000358276.5 |
MLIP
|
muscular LMNA-interacting protein |
| chr15_+_65337708 | 3.23 |
ENST00000334287.2
|
SLC51B
|
solute carrier family 51, beta subunit |
| chr8_-_93115445 | 3.21 |
ENST00000523629.1
|
RUNX1T1
|
runt-related transcription factor 1; translocated to, 1 (cyclin D-related) |
| chr2_+_223916862 | 3.16 |
ENST00000604125.1
|
KCNE4
|
potassium voltage-gated channel, Isk-related family, member 4 |
| chr5_-_147211226 | 3.16 |
ENST00000296695.5
|
SPINK1
|
serine peptidase inhibitor, Kazal type 1 |
| chr14_-_38725573 | 3.13 |
ENST00000342213.2
|
CLEC14A
|
C-type lectin domain family 14, member A |
| chr15_+_33010175 | 3.12 |
ENST00000300177.4
ENST00000560677.1 ENST00000560830.1 |
GREM1
|
gremlin 1, DAN family BMP antagonist |
| chr12_-_56105880 | 3.08 |
ENST00000557257.1
|
ITGA7
|
integrin, alpha 7 |
| chr9_+_133986782 | 3.08 |
ENST00000372301.2
|
AIF1L
|
allograft inflammatory factor 1-like |
| chr15_+_96875657 | 3.06 |
ENST00000559679.1
ENST00000394171.2 |
NR2F2
|
nuclear receptor subfamily 2, group F, member 2 |
| chr9_-_34381536 | 3.03 |
ENST00000379126.3
ENST00000379127.1 ENST00000379133.3 |
C9orf24
|
chromosome 9 open reading frame 24 |
| chr13_-_110959478 | 3.02 |
ENST00000543140.1
ENST00000375820.4 |
COL4A1
|
collagen, type IV, alpha 1 |
| chr9_-_35691017 | 3.01 |
ENST00000378292.3
|
TPM2
|
tropomyosin 2 (beta) |
| chrX_+_38420623 | 2.99 |
ENST00000378482.2
|
TSPAN7
|
tetraspanin 7 |
| chr7_-_95225768 | 2.94 |
ENST00000005178.5
|
PDK4
|
pyruvate dehydrogenase kinase, isozyme 4 |
| chr15_-_65067773 | 2.90 |
ENST00000300069.4
|
RBPMS2
|
RNA binding protein with multiple splicing 2 |
| chr6_-_76072719 | 2.89 |
ENST00000370020.1
|
FILIP1
|
filamin A interacting protein 1 |
| chrX_+_38420783 | 2.88 |
ENST00000422612.2
ENST00000286824.6 ENST00000545599.1 |
TSPAN7
|
tetraspanin 7 |
| chr11_+_117073850 | 2.88 |
ENST00000529622.1
|
TAGLN
|
transgelin |
| chr7_-_44365020 | 2.87 |
ENST00000395747.2
ENST00000347193.4 ENST00000346990.4 ENST00000258682.6 ENST00000353625.4 ENST00000421607.1 ENST00000424197.1 ENST00000502837.2 ENST00000350811.3 ENST00000395749.2 |
CAMK2B
|
calcium/calmodulin-dependent protein kinase II beta |
| chr5_-_83680603 | 2.87 |
ENST00000296591.5
|
EDIL3
|
EGF-like repeats and discoidin I-like domains 3 |
| chr1_-_79472365 | 2.86 |
ENST00000370742.3
|
ELTD1
|
EGF, latrophilin and seven transmembrane domain containing 1 |
| chr1_+_153600869 | 2.79 |
ENST00000292169.1
ENST00000368696.3 ENST00000436839.1 |
S100A1
|
S100 calcium binding protein A1 |
| chr21_+_40817749 | 2.79 |
ENST00000380637.3
ENST00000380634.1 ENST00000458295.1 ENST00000440288.2 ENST00000380631.1 |
SH3BGR
|
SH3 domain binding glutamic acid-rich protein |
| chr16_+_55357672 | 2.77 |
ENST00000290552.7
|
IRX6
|
iroquois homeobox 6 |
| chr16_-_31439735 | 2.77 |
ENST00000287490.4
|
COX6A2
|
cytochrome c oxidase subunit VIa polypeptide 2 |
| chr6_-_75912508 | 2.75 |
ENST00000416123.2
|
COL12A1
|
collagen, type XII, alpha 1 |
| chr1_-_26394114 | 2.74 |
ENST00000374272.3
|
TRIM63
|
tripartite motif containing 63, E3 ubiquitin protein ligase |
| chr20_-_61051026 | 2.73 |
ENST00000252997.2
|
GATA5
|
GATA binding protein 5 |
| chr5_-_146781153 | 2.73 |
ENST00000520473.1
|
DPYSL3
|
dihydropyrimidinase-like 3 |
| chr16_+_55522536 | 2.70 |
ENST00000570283.1
|
MMP2
|
matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) |
| chr3_+_45067659 | 2.68 |
ENST00000296130.4
|
CLEC3B
|
C-type lectin domain family 3, member B |
| chr12_-_91573249 | 2.68 |
ENST00000550099.1
ENST00000546391.1 ENST00000551354.1 |
DCN
|
decorin |
| chr3_+_52828805 | 2.67 |
ENST00000416872.2
ENST00000449956.2 |
ITIH3
|
inter-alpha-trypsin inhibitor heavy chain 3 |
| chr19_-_58485895 | 2.66 |
ENST00000314391.3
|
C19orf18
|
chromosome 19 open reading frame 18 |
| chr12_-_96184533 | 2.65 |
ENST00000343702.4
ENST00000344911.4 |
NTN4
|
netrin 4 |
| chr6_+_53976285 | 2.63 |
ENST00000514433.1
|
MLIP
|
muscular LMNA-interacting protein |
| chr1_+_55107449 | 2.62 |
ENST00000421030.2
ENST00000545244.1 ENST00000339553.5 ENST00000409996.1 ENST00000454855.2 |
MROH7
|
maestro heat-like repeat family member 7 |
| chr12_+_58013693 | 2.62 |
ENST00000320442.4
ENST00000379218.2 |
SLC26A10
|
solute carrier family 26, member 10 |
| chr7_+_79764104 | 2.60 |
ENST00000351004.3
|
GNAI1
|
guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 1 |
| chr11_-_35547572 | 2.60 |
ENST00000378880.2
|
PAMR1
|
peptidase domain containing associated with muscle regeneration 1 |
| chr22_+_51176624 | 2.60 |
ENST00000216139.5
ENST00000529621.1 |
ACR
|
acrosin |
| chr4_-_186696636 | 2.60 |
ENST00000444771.1
|
SORBS2
|
sorbin and SH3 domain containing 2 |
| chr1_-_144994909 | 2.58 |
ENST00000369347.4
ENST00000369354.3 |
PDE4DIP
|
phosphodiesterase 4D interacting protein |
| chr12_+_119616447 | 2.56 |
ENST00000281938.2
|
HSPB8
|
heat shock 22kDa protein 8 |
| chr1_-_116311402 | 2.56 |
ENST00000261448.5
|
CASQ2
|
calsequestrin 2 (cardiac muscle) |
| chr17_+_53344945 | 2.55 |
ENST00000575345.1
|
HLF
|
hepatic leukemia factor |
| chr5_+_170288856 | 2.55 |
ENST00000523189.1
|
RANBP17
|
RAN binding protein 17 |
| chr5_+_78985673 | 2.55 |
ENST00000446378.2
|
CMYA5
|
cardiomyopathy associated 5 |
| chr13_-_33760216 | 2.53 |
ENST00000255486.4
|
STARD13
|
StAR-related lipid transfer (START) domain containing 13 |
| chr11_+_111783450 | 2.52 |
ENST00000537382.1
|
HSPB2
|
Homo sapiens heat shock 27kDa protein 2 (HSPB2), mRNA. |
| chr15_+_96876340 | 2.51 |
ENST00000453270.2
|
NR2F2
|
nuclear receptor subfamily 2, group F, member 2 |
| chr12_-_114843889 | 2.50 |
ENST00000405440.2
|
TBX5
|
T-box 5 |
| chr14_+_105212297 | 2.49 |
ENST00000556623.1
ENST00000555674.1 |
ADSSL1
|
adenylosuccinate synthase like 1 |
| chr3_-_116164306 | 2.48 |
ENST00000490035.2
|
LSAMP
|
limbic system-associated membrane protein |
| chr10_-_97175444 | 2.48 |
ENST00000486141.2
|
SORBS1
|
sorbin and SH3 domain containing 1 |
| chr1_+_160085501 | 2.48 |
ENST00000361216.3
|
ATP1A2
|
ATPase, Na+/K+ transporting, alpha 2 polypeptide |
| chr12_+_58003935 | 2.46 |
ENST00000333972.7
|
ARHGEF25
|
Rho guanine nucleotide exchange factor (GEF) 25 |
| chrX_-_21776281 | 2.46 |
ENST00000379494.3
|
SMPX
|
small muscle protein, X-linked |
| chr5_+_40909354 | 2.46 |
ENST00000313164.9
|
C7
|
complement component 7 |
| chr9_+_74764340 | 2.46 |
ENST00000376986.1
ENST00000358399.3 |
GDA
|
guanine deaminase |
| chrX_-_15619076 | 2.46 |
ENST00000252519.3
|
ACE2
|
angiotensin I converting enzyme 2 |
| chr12_-_16759440 | 2.43 |
ENST00000537304.1
|
LMO3
|
LIM domain only 3 (rhombotin-like 2) |
| chr13_+_53602894 | 2.42 |
ENST00000219022.2
|
OLFM4
|
olfactomedin 4 |
| chr9_-_35685452 | 2.40 |
ENST00000607559.1
|
TPM2
|
tropomyosin 2 (beta) |
| chr10_-_29811456 | 2.40 |
ENST00000535393.1
|
SVIL
|
supervillin |
| chr7_+_95401851 | 2.40 |
ENST00000447467.2
|
DYNC1I1
|
dynein, cytoplasmic 1, intermediate chain 1 |
| chr7_+_30960915 | 2.39 |
ENST00000441328.2
ENST00000409899.1 ENST00000409611.1 |
AQP1
|
aquaporin 1 (Colton blood group) |
| chr9_-_34665983 | 2.38 |
ENST00000416454.1
ENST00000544078.2 ENST00000421828.2 ENST00000423809.1 |
RP11-195F19.5
|
HCG2040265, isoform CRA_a; Uncharacterized protein; cDNA FLJ50015 |
| chr19_-_11308190 | 2.37 |
ENST00000586659.1
ENST00000592903.1 ENST00000589359.1 ENST00000588724.1 ENST00000432929.2 |
KANK2
|
KN motif and ankyrin repeat domains 2 |
| chr4_+_113739244 | 2.36 |
ENST00000503271.1
ENST00000503423.1 ENST00000506722.1 |
ANK2
|
ankyrin 2, neuronal |
| chr10_-_115423792 | 2.36 |
ENST00000369360.3
ENST00000360478.3 ENST00000359988.3 ENST00000369358.4 |
NRAP
|
nebulin-related anchoring protein |
| chr12_-_96184913 | 2.35 |
ENST00000538383.1
|
NTN4
|
netrin 4 |
| chr2_+_46524537 | 2.34 |
ENST00000263734.3
|
EPAS1
|
endothelial PAS domain protein 1 |
| chr1_+_22979474 | 2.34 |
ENST00000509305.1
|
C1QB
|
complement component 1, q subcomponent, B chain |
| chr8_-_107782463 | 2.33 |
ENST00000311955.3
|
ABRA
|
actin-binding Rho activating protein |
| chr17_+_53345080 | 2.33 |
ENST00000572002.1
|
HLF
|
hepatic leukemia factor |
| chr14_-_35183755 | 2.32 |
ENST00000555765.1
|
CFL2
|
cofilin 2 (muscle) |
| chr16_+_71392616 | 2.32 |
ENST00000349553.5
ENST00000302628.4 ENST00000562305.1 |
CALB2
|
calbindin 2 |
| chrX_-_31285042 | 2.32 |
ENST00000378680.2
ENST00000378723.3 |
DMD
|
dystrophin |
| chr17_-_38256973 | 2.32 |
ENST00000246672.3
|
NR1D1
|
nuclear receptor subfamily 1, group D, member 1 |
| chr8_+_98900132 | 2.31 |
ENST00000520016.1
|
MATN2
|
matrilin 2 |
| chr3_-_149388682 | 2.31 |
ENST00000475579.1
|
WWTR1
|
WW domain containing transcription regulator 1 |
| chrX_+_46937745 | 2.30 |
ENST00000397180.1
ENST00000457380.1 ENST00000352078.4 |
RGN
|
regucalcin |
| chr12_-_91576561 | 2.30 |
ENST00000547568.2
ENST00000552962.1 |
DCN
|
decorin |
| chr1_+_47264711 | 2.29 |
ENST00000371923.4
ENST00000271153.4 ENST00000371919.4 |
CYP4B1
|
cytochrome P450, family 4, subfamily B, polypeptide 1 |
| chr9_-_129884902 | 2.29 |
ENST00000373417.1
|
ANGPTL2
|
angiopoietin-like 2 |
| chr1_+_20396649 | 2.29 |
ENST00000375108.3
|
PLA2G5
|
phospholipase A2, group V |
| chr1_+_46640750 | 2.28 |
ENST00000372003.1
|
TSPAN1
|
tetraspanin 1 |
| chr3_-_42744312 | 2.28 |
ENST00000416756.1
ENST00000441594.1 |
HHATL
|
hedgehog acyltransferase-like |
| chr4_+_20255123 | 2.28 |
ENST00000504154.1
ENST00000273739.5 |
SLIT2
|
slit homolog 2 (Drosophila) |
| chr1_-_116311323 | 2.28 |
ENST00000456138.2
|
CASQ2
|
calsequestrin 2 (cardiac muscle) |
| chrX_+_152760397 | 2.28 |
ENST00000331595.4
ENST00000431891.1 |
BGN
|
biglycan |
| chr3_+_119316721 | 2.26 |
ENST00000488919.1
ENST00000495992.1 |
PLA1A
|
phospholipase A1 member A |
| chr13_+_103046954 | 2.26 |
ENST00000606448.1
|
FGF14-AS2
|
FGF14 antisense RNA 2 |
| chr12_-_91573132 | 2.26 |
ENST00000550563.1
ENST00000546370.1 |
DCN
|
decorin |
| chr3_+_12330560 | 2.24 |
ENST00000397026.2
|
PPARG
|
peroxisome proliferator-activated receptor gamma |
| chr7_+_117864708 | 2.24 |
ENST00000357099.4
ENST00000265224.4 ENST00000486422.1 ENST00000417525.1 |
ANKRD7
|
ankyrin repeat domain 7 |
| chr9_-_129885010 | 2.24 |
ENST00000373425.3
|
ANGPTL2
|
angiopoietin-like 2 |
| chr15_+_85359911 | 2.23 |
ENST00000258888.5
|
ALPK3
|
alpha-kinase 3 |
| chr9_-_104249400 | 2.23 |
ENST00000374848.3
|
TMEM246
|
transmembrane protein 246 |
| chr12_-_9268707 | 2.23 |
ENST00000318602.7
|
A2M
|
alpha-2-macroglobulin |
| chr2_+_217498105 | 2.23 |
ENST00000233809.4
|
IGFBP2
|
insulin-like growth factor binding protein 2, 36kDa |
| chr12_-_8814669 | 2.23 |
ENST00000535411.1
ENST00000540087.1 |
MFAP5
|
microfibrillar associated protein 5 |
| chr3_-_24536453 | 2.22 |
ENST00000453729.2
ENST00000413780.1 |
THRB
|
thyroid hormone receptor, beta |
| chr4_+_24797085 | 2.22 |
ENST00000382120.3
|
SOD3
|
superoxide dismutase 3, extracellular |
| chr3_-_42744130 | 2.22 |
ENST00000417472.1
ENST00000442469.1 |
HHATL
|
hedgehog acyltransferase-like |
| chr22_-_36236623 | 2.21 |
ENST00000405409.2
|
RBFOX2
|
RNA binding protein, fox-1 homolog (C. elegans) 2 |
| chrX_+_135230712 | 2.21 |
ENST00000535737.1
|
FHL1
|
four and a half LIM domains 1 |
| chr8_+_136470270 | 2.20 |
ENST00000524199.1
|
KHDRBS3
|
KH domain containing, RNA binding, signal transduction associated 3 |
| chr7_+_94536898 | 2.20 |
ENST00000433360.1
ENST00000340694.4 ENST00000424654.1 |
PPP1R9A
|
protein phosphatase 1, regulatory subunit 9A |
| chr3_+_14860469 | 2.20 |
ENST00000285046.5
|
FGD5
|
FYVE, RhoGEF and PH domain containing 5 |
| chr13_+_113633620 | 2.20 |
ENST00000421756.1
ENST00000375601.3 |
MCF2L
|
MCF.2 cell line derived transforming sequence-like |
| chr2_+_220492116 | 2.20 |
ENST00000373760.2
|
SLC4A3
|
solute carrier family 4 (anion exchanger), member 3 |
| chr6_+_142623063 | 2.19 |
ENST00000296932.8
ENST00000367609.3 |
GPR126
|
G protein-coupled receptor 126 |
| chr1_+_22962948 | 2.18 |
ENST00000374642.3
|
C1QA
|
complement component 1, q subcomponent, A chain |
| chr2_+_242127924 | 2.17 |
ENST00000402530.3
ENST00000274979.8 ENST00000402430.3 |
ANO7
|
anoctamin 7 |
| chr12_-_91576750 | 2.17 |
ENST00000228329.5
ENST00000303320.3 ENST00000052754.5 |
DCN
|
decorin |
| chr11_+_20044600 | 2.17 |
ENST00000311043.8
|
NAV2
|
neuron navigator 2 |
| chr19_-_51289436 | 2.16 |
ENST00000562076.1
|
CTD-2568A17.1
|
CTD-2568A17.1 |
| chr1_-_31661000 | 2.16 |
ENST00000263693.1
ENST00000398657.2 ENST00000526106.1 |
NKAIN1
|
Na+/K+ transporting ATPase interacting 1 |
| chr15_+_71184931 | 2.15 |
ENST00000560369.1
ENST00000260382.5 |
LRRC49
|
leucine rich repeat containing 49 |
| chr10_+_123970670 | 2.14 |
ENST00000496913.2
|
TACC2
|
transforming, acidic coiled-coil containing protein 2 |
| chr1_+_22979676 | 2.14 |
ENST00000432749.2
ENST00000314933.6 |
C1QB
|
complement component 1, q subcomponent, B chain |
| chr7_+_79765071 | 2.14 |
ENST00000457358.2
|
GNAI1
|
guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 1 |
| chr4_+_76932326 | 2.14 |
ENST00000513353.1
ENST00000341029.5 |
ART3
|
ADP-ribosyltransferase 3 |
| chr3_-_117716418 | 2.13 |
ENST00000484092.1
|
RP11-384F7.2
|
RP11-384F7.2 |
| chr3_+_159557637 | 2.13 |
ENST00000445224.2
|
SCHIP1
|
schwannomin interacting protein 1 |
| chrX_-_43741594 | 2.11 |
ENST00000536181.1
ENST00000378069.4 |
MAOB
|
monoamine oxidase B |
| chr7_+_116165754 | 2.11 |
ENST00000405348.1
|
CAV1
|
caveolin 1, caveolae protein, 22kDa |
| chr16_-_4987065 | 2.11 |
ENST00000590782.2
ENST00000345988.2 |
PPL
|
periplakin |
| chr19_+_11649532 | 2.09 |
ENST00000252456.2
ENST00000592923.1 ENST00000535659.2 |
CNN1
|
calponin 1, basic, smooth muscle |
| chr1_-_12679171 | 2.09 |
ENST00000606790.1
|
RP11-474O21.5
|
RP11-474O21.5 |
| chr12_+_27849378 | 2.09 |
ENST00000310791.2
|
REP15
|
RAB15 effector protein |
| chr9_-_34381511 | 2.09 |
ENST00000379124.1
|
C9orf24
|
chromosome 9 open reading frame 24 |
| chr1_+_233765353 | 2.06 |
ENST00000366620.1
|
KCNK1
|
potassium channel, subfamily K, member 1 |
| chr12_-_15865844 | 2.06 |
ENST00000543612.1
|
EPS8
|
epidermal growth factor receptor pathway substrate 8 |
| chr14_-_67859422 | 2.06 |
ENST00000556532.1
|
PLEK2
|
pleckstrin 2 |
| chr1_-_39395165 | 2.04 |
ENST00000372985.3
|
RHBDL2
|
rhomboid, veinlet-like 2 (Drosophila) |
| chr7_+_70597109 | 2.04 |
ENST00000333538.5
|
WBSCR17
|
Williams-Beuren syndrome chromosome region 17 |
| chr9_+_69650263 | 2.04 |
ENST00000322495.3
|
AL445665.1
|
Protein LOC100996643 |
| chr7_+_37960163 | 2.03 |
ENST00000199448.4
ENST00000559325.1 ENST00000423717.1 |
EPDR1
|
ependymin related 1 |
| chr3_+_119316689 | 2.03 |
ENST00000273371.4
|
PLA1A
|
phospholipase A1 member A |
| chr11_+_1942580 | 2.03 |
ENST00000381558.1
|
TNNT3
|
troponin T type 3 (skeletal, fast) |
| chr12_+_81471816 | 2.02 |
ENST00000261206.3
|
ACSS3
|
acyl-CoA synthetase short-chain family member 3 |
| chr1_+_66999799 | 2.02 |
ENST00000371035.3
ENST00000371036.3 ENST00000371037.4 |
SGIP1
|
SH3-domain GRB2-like (endophilin) interacting protein 1 |
| chr8_-_17533838 | 2.01 |
ENST00000400046.1
|
MTUS1
|
microtubule associated tumor suppressor 1 |
| chr6_-_33714752 | 2.01 |
ENST00000451316.1
|
IP6K3
|
inositol hexakisphosphate kinase 3 |
| chr19_-_46974741 | 2.01 |
ENST00000313683.10
ENST00000602246.1 |
PNMAL1
|
paraneoplastic Ma antigen family-like 1 |
| chr19_-_35625765 | 2.01 |
ENST00000591633.1
|
LGI4
|
leucine-rich repeat LGI family, member 4 |
| chr1_-_177939348 | 2.00 |
ENST00000464631.2
|
SEC16B
|
SEC16 homolog B (S. cerevisiae) |
| chr12_-_57634475 | 2.00 |
ENST00000393825.1
|
NDUFA4L2
|
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 4-like 2 |
| chr19_+_6739662 | 1.99 |
ENST00000313285.8
ENST00000313244.9 ENST00000596758.1 |
TRIP10
|
thyroid hormone receptor interactor 10 |
| chr2_+_168043793 | 1.97 |
ENST00000409273.1
ENST00000409605.1 |
XIRP2
|
xin actin-binding repeat containing 2 |
| chrX_-_31284974 | 1.97 |
ENST00000378702.4
|
DMD
|
dystrophin |
| chr5_-_38556728 | 1.96 |
ENST00000506990.1
ENST00000453190.2 |
LIFR
|
leukemia inhibitory factor receptor alpha |
| chr17_+_1665306 | 1.96 |
ENST00000571360.1
|
SERPINF1
|
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1 |
| chr12_+_12938541 | 1.96 |
ENST00000356591.4
|
APOLD1
|
apolipoprotein L domain containing 1 |
Network of associatons between targets according to the STRING database.
First level regulatory network of RARG
Gene Ontology Analysis
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 5.2 | 15.7 | GO:1901202 | negative regulation of extracellular matrix assembly(GO:1901202) |
| 3.3 | 9.9 | GO:1903280 | negative regulation of calcium:sodium antiporter activity(GO:1903280) |
| 1.6 | 6.2 | GO:1903060 | regulation of N-terminal protein palmitoylation(GO:0060254) negative regulation of N-terminal protein palmitoylation(GO:0060262) negative regulation of protein lipidation(GO:1903060) |
| 1.4 | 1.4 | GO:0006789 | bilirubin conjugation(GO:0006789) |
| 1.4 | 4.2 | GO:0001868 | regulation of complement activation, lectin pathway(GO:0001868) negative regulation of complement activation, lectin pathway(GO:0001869) |
| 1.4 | 5.6 | GO:0009956 | radial pattern formation(GO:0009956) |
| 1.3 | 4.0 | GO:1903625 | negative regulation of DNA catabolic process(GO:1903625) regulation of aminoacyl-tRNA ligase activity(GO:1903630) |
| 1.3 | 6.6 | GO:0008050 | female courtship behavior(GO:0008050) |
| 1.3 | 18.4 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
| 1.3 | 3.9 | GO:0006147 | guanine catabolic process(GO:0006147) |
| 1.3 | 5.0 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
| 1.2 | 3.7 | GO:0043449 | cellular alkene metabolic process(GO:0043449) |
| 1.2 | 4.8 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
| 1.2 | 5.8 | GO:0036371 | protein localization to T-tubule(GO:0036371) |
| 1.2 | 3.5 | GO:1901899 | positive regulation of relaxation of cardiac muscle(GO:1901899) regulation of calcium ion import into sarcoplasmic reticulum(GO:1902080) negative regulation of calcium ion import into sarcoplasmic reticulum(GO:1902081) |
| 1.0 | 3.1 | GO:1900158 | negative regulation of bone mineralization involved in bone maturation(GO:1900158) |
| 1.0 | 5.0 | GO:0021812 | neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
| 1.0 | 3.8 | GO:0090119 | vesicle-mediated cholesterol transport(GO:0090119) |
| 0.9 | 14.2 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
| 0.9 | 4.7 | GO:1900106 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
| 0.9 | 2.8 | GO:0061033 | secretion by lung epithelial cell involved in lung growth(GO:0061033) |
| 0.9 | 2.8 | GO:1904956 | regulation of midbrain dopaminergic neuron differentiation(GO:1904956) |
| 0.9 | 3.6 | GO:1904049 | negative regulation of spontaneous neurotransmitter secretion(GO:1904049) |
| 0.8 | 2.5 | GO:0003218 | cardiac left ventricle formation(GO:0003218) |
| 0.8 | 2.4 | GO:0035378 | carbon dioxide transmembrane transport(GO:0035378) |
| 0.8 | 2.4 | GO:0070563 | negative regulation of vitamin D receptor signaling pathway(GO:0070563) |
| 0.8 | 2.3 | GO:0060086 | circadian temperature homeostasis(GO:0060086) |
| 0.8 | 4.6 | GO:1903598 | positive regulation of gap junction assembly(GO:1903598) |
| 0.8 | 2.3 | GO:0071676 | negative regulation of mononuclear cell migration(GO:0071676) |
| 0.7 | 2.2 | GO:2000532 | renal albumin absorption(GO:0097018) regulation of renal albumin absorption(GO:2000532) regulation of platelet-derived growth factor receptor-alpha signaling pathway(GO:2000583) negative regulation of platelet-derived growth factor receptor-alpha signaling pathway(GO:2000584) |
| 0.7 | 4.4 | GO:0042335 | cuticle development(GO:0042335) |
| 0.7 | 2.6 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
| 0.6 | 4.5 | GO:0030241 | skeletal muscle myosin thick filament assembly(GO:0030241) |
| 0.6 | 1.9 | GO:0051492 | regulation of stress fiber assembly(GO:0051492) |
| 0.6 | 1.9 | GO:0072720 | response to dithiothreitol(GO:0072720) |
| 0.6 | 4.5 | GO:0071279 | cellular response to cobalt ion(GO:0071279) |
| 0.6 | 1.9 | GO:2000824 | negative regulation of androgen receptor activity(GO:2000824) |
| 0.6 | 1.9 | GO:0043438 | acetoacetic acid metabolic process(GO:0043438) |
| 0.6 | 3.8 | GO:0010751 | negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
| 0.6 | 1.9 | GO:0031446 | regulation of fast-twitch skeletal muscle fiber contraction(GO:0031446) positive regulation of fast-twitch skeletal muscle fiber contraction(GO:0031448) |
| 0.6 | 4.2 | GO:0015793 | glycerol transport(GO:0015793) |
| 0.6 | 14.9 | GO:0007021 | tubulin complex assembly(GO:0007021) |
| 0.6 | 4.7 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
| 0.6 | 5.2 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
| 0.6 | 1.2 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
| 0.6 | 2.3 | GO:0061763 | multivesicular body-lysosome fusion(GO:0061763) |
| 0.6 | 8.7 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
| 0.6 | 3.4 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
| 0.6 | 1.7 | GO:0032242 | regulation of nucleoside transport(GO:0032242) |
| 0.6 | 2.2 | GO:2000230 | negative regulation of pancreatic stellate cell proliferation(GO:2000230) |
| 0.6 | 4.4 | GO:0051891 | positive regulation of cardioblast differentiation(GO:0051891) |
| 0.6 | 1.1 | GO:0043506 | regulation of JUN kinase activity(GO:0043506) |
| 0.5 | 2.7 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
| 0.5 | 2.7 | GO:0097089 | methyl-branched fatty acid metabolic process(GO:0097089) |
| 0.5 | 3.7 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
| 0.5 | 2.1 | GO:0006781 | succinyl-CoA pathway(GO:0006781) |
| 0.5 | 3.1 | GO:0033159 | negative regulation of protein import into nucleus, translocation(GO:0033159) |
| 0.5 | 3.1 | GO:0021539 | subthalamus development(GO:0021539) |
| 0.5 | 3.0 | GO:2001295 | malonyl-CoA biosynthetic process(GO:2001295) |
| 0.5 | 2.5 | GO:0044208 | 'de novo' AMP biosynthetic process(GO:0044208) |
| 0.5 | 2.0 | GO:0021849 | neuroblast division in subventricular zone(GO:0021849) |
| 0.5 | 1.5 | GO:1902548 | negative regulation of cellular response to vascular endothelial growth factor stimulus(GO:1902548) |
| 0.5 | 4.4 | GO:0021564 | vagus nerve development(GO:0021564) |
| 0.5 | 2.4 | GO:0097017 | renal protein absorption(GO:0097017) |
| 0.5 | 8.8 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
| 0.5 | 2.9 | GO:0030421 | defecation(GO:0030421) |
| 0.5 | 5.6 | GO:2000576 | positive regulation of microtubule motor activity(GO:2000576) regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
| 0.5 | 1.8 | GO:2000820 | negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000820) |
| 0.5 | 1.4 | GO:0061394 | regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance(GO:0061394) |
| 0.5 | 1.4 | GO:0051780 | mevalonate transport(GO:0015728) behavioral response to nutrient(GO:0051780) |
| 0.5 | 3.6 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
| 0.5 | 0.9 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
| 0.4 | 6.3 | GO:0086068 | Purkinje myocyte to ventricular cardiac muscle cell signaling(GO:0086029) Purkinje myocyte to ventricular cardiac muscle cell communication(GO:0086068) |
| 0.4 | 1.8 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
| 0.4 | 2.2 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
| 0.4 | 1.8 | GO:0097115 | cytoskeletal matrix organization at active zone(GO:0048789) neurexin clustering involved in presynaptic membrane assembly(GO:0097115) retrograde trans-synaptic signaling by trans-synaptic protein complex(GO:0098942) |
| 0.4 | 1.7 | GO:0060166 | olfactory pit development(GO:0060166) |
| 0.4 | 0.9 | GO:1903949 | positive regulation of atrial cardiac muscle cell action potential(GO:1903949) |
| 0.4 | 2.5 | GO:0097498 | endothelial tube lumen extension(GO:0097498) |
| 0.4 | 2.9 | GO:0014718 | positive regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014718) |
| 0.4 | 5.4 | GO:1903273 | regulation of sodium ion export(GO:1903273) positive regulation of sodium ion export(GO:1903275) regulation of sodium ion export from cell(GO:1903276) positive regulation of sodium ion export from cell(GO:1903278) |
| 0.4 | 1.2 | GO:0002894 | positive regulation of type IIa hypersensitivity(GO:0001798) positive regulation of type II hypersensitivity(GO:0002894) |
| 0.4 | 1.6 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
| 0.4 | 1.2 | GO:0061193 | sensory organ boundary specification(GO:0008052) formation of organ boundary(GO:0010160) taste bud development(GO:0061193) |
| 0.4 | 6.8 | GO:1904322 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
| 0.4 | 2.0 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
| 0.4 | 0.8 | GO:0003051 | angiotensin-mediated drinking behavior(GO:0003051) |
| 0.4 | 1.5 | GO:0021784 | postganglionic parasympathetic fiber development(GO:0021784) |
| 0.4 | 2.6 | GO:0051012 | microtubule sliding(GO:0051012) |
| 0.4 | 0.7 | GO:0060435 | bronchiole development(GO:0060435) |
| 0.4 | 3.3 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
| 0.4 | 17.4 | GO:0003298 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
| 0.4 | 3.6 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
| 0.3 | 1.0 | GO:0003050 | regulation of systemic arterial blood pressure by atrial natriuretic peptide(GO:0003050) |
| 0.3 | 4.5 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
| 0.3 | 6.1 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
| 0.3 | 1.0 | GO:0042137 | sequestering of neurotransmitter(GO:0042137) |
| 0.3 | 3.3 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
| 0.3 | 1.3 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
| 0.3 | 2.3 | GO:0032971 | regulation of muscle filament sliding(GO:0032971) |
| 0.3 | 3.3 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
| 0.3 | 3.3 | GO:2000389 | regulation of neutrophil extravasation(GO:2000389) |
| 0.3 | 1.3 | GO:0010903 | negative regulation of very-low-density lipoprotein particle remodeling(GO:0010903) |
| 0.3 | 1.6 | GO:0036414 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
| 0.3 | 1.9 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
| 0.3 | 1.3 | GO:0048808 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
| 0.3 | 1.0 | GO:0042701 | progesterone secretion(GO:0042701) |
| 0.3 | 1.6 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
| 0.3 | 2.5 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
| 0.3 | 5.8 | GO:0008212 | mineralocorticoid biosynthetic process(GO:0006705) mineralocorticoid metabolic process(GO:0008212) |
| 0.3 | 2.4 | GO:0048014 | Tie signaling pathway(GO:0048014) |
| 0.3 | 2.1 | GO:0008218 | bioluminescence(GO:0008218) |
| 0.3 | 5.1 | GO:0006108 | malate metabolic process(GO:0006108) |
| 0.3 | 1.5 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
| 0.3 | 2.4 | GO:0003322 | pancreatic A cell development(GO:0003322) |
| 0.3 | 1.2 | GO:0001971 | negative regulation of activation of membrane attack complex(GO:0001971) |
| 0.3 | 3.5 | GO:0046959 | habituation(GO:0046959) |
| 0.3 | 4.0 | GO:0007258 | JUN phosphorylation(GO:0007258) |
| 0.3 | 3.1 | GO:0035524 | proline transmembrane transport(GO:0035524) |
| 0.3 | 2.0 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
| 0.3 | 1.4 | GO:2000698 | positive regulation of epithelial cell differentiation involved in kidney development(GO:2000698) |
| 0.3 | 1.4 | GO:0016185 | synaptic vesicle budding from presynaptic endocytic zone membrane(GO:0016185) |
| 0.3 | 0.6 | GO:0048627 | myoblast development(GO:0048627) |
| 0.3 | 1.4 | GO:1901668 | regulation of superoxide dismutase activity(GO:1901668) |
| 0.3 | 4.4 | GO:0046069 | cGMP catabolic process(GO:0046069) |
| 0.3 | 0.8 | GO:0042264 | peptidyl-aspartic acid hydroxylation(GO:0042264) |
| 0.3 | 0.5 | GO:0014034 | neural crest cell fate commitment(GO:0014034) |
| 0.3 | 2.1 | GO:0014063 | negative regulation of serotonin secretion(GO:0014063) |
| 0.3 | 1.3 | GO:0060301 | vestibulocochlear nerve structural organization(GO:0021649) positive regulation of cytokine activity(GO:0060301) ganglion morphogenesis(GO:0061552) VEGF-activated neuropilin signaling pathway involved in axon guidance(GO:1902378) dorsal root ganglion morphogenesis(GO:1904835) otic placode development(GO:1905040) |
| 0.3 | 1.0 | GO:0018277 | protein deamination(GO:0018277) |
| 0.3 | 0.5 | GO:0045925 | positive regulation of female receptivity(GO:0045925) |
| 0.3 | 0.5 | GO:0010002 | cardioblast differentiation(GO:0010002) |
| 0.3 | 3.1 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
| 0.3 | 0.8 | GO:0060615 | fibroblast growth factor receptor signaling pathway involved in mammary gland specification(GO:0060595) mammary gland bud formation(GO:0060615) branch elongation involved in salivary gland morphogenesis(GO:0060667) mesenchymal cell differentiation involved in lung development(GO:0060915) |
| 0.3 | 2.3 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
| 0.3 | 1.3 | GO:0072233 | thick ascending limb development(GO:0072023) metanephric thick ascending limb development(GO:0072233) |
| 0.2 | 0.7 | GO:0045360 | regulation of interleukin-1 biosynthetic process(GO:0045360) positive regulation of interleukin-1 biosynthetic process(GO:0045362) |
| 0.2 | 0.7 | GO:0070305 | response to cGMP(GO:0070305) |
| 0.2 | 2.4 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
| 0.2 | 1.2 | GO:0030822 | positive regulation of cyclic nucleotide catabolic process(GO:0030807) positive regulation of cAMP catabolic process(GO:0030822) positive regulation of purine nucleotide catabolic process(GO:0033123) |
| 0.2 | 0.5 | GO:1902612 | regulation of anti-Mullerian hormone signaling pathway(GO:1902612) negative regulation of anti-Mullerian hormone signaling pathway(GO:1902613) anti-Mullerian hormone signaling pathway(GO:1990262) |
| 0.2 | 1.0 | GO:0042109 | lymphotoxin A production(GO:0032641) lymphotoxin A biosynthetic process(GO:0042109) |
| 0.2 | 1.7 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
| 0.2 | 1.0 | GO:0035262 | gonad morphogenesis(GO:0035262) |
| 0.2 | 6.8 | GO:1901881 | positive regulation of protein depolymerization(GO:1901881) |
| 0.2 | 3.1 | GO:0001778 | plasma membrane repair(GO:0001778) |
| 0.2 | 5.0 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
| 0.2 | 6.4 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
| 0.2 | 1.4 | GO:1903224 | regulation of endodermal cell differentiation(GO:1903224) |
| 0.2 | 4.0 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
| 0.2 | 0.9 | GO:1904106 | protein localization to microvillus(GO:1904106) |
| 0.2 | 2.3 | GO:0042415 | norepinephrine metabolic process(GO:0042415) surfactant homeostasis(GO:0043129) |
| 0.2 | 0.5 | GO:0060061 | Spemann organizer formation(GO:0060061) |
| 0.2 | 1.8 | GO:0032484 | Ral protein signal transduction(GO:0032484) regulation of Ral protein signal transduction(GO:0032485) |
| 0.2 | 0.9 | GO:1904823 | pyrimidine nucleobase transport(GO:0015855) purine nucleobase transmembrane transport(GO:1904823) |
| 0.2 | 1.5 | GO:0014846 | esophagus smooth muscle contraction(GO:0014846) |
| 0.2 | 1.1 | GO:1903070 | negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
| 0.2 | 2.6 | GO:1990573 | potassium ion import across plasma membrane(GO:1990573) |
| 0.2 | 2.8 | GO:1901387 | positive regulation of voltage-gated calcium channel activity(GO:1901387) |
| 0.2 | 0.6 | GO:0001207 | histone displacement(GO:0001207) positive regulation of transcription involved in meiotic cell cycle(GO:0051039) |
| 0.2 | 0.9 | GO:0019056 | modulation by virus of host transcription(GO:0019056) positive regulation of sprouting of injured axon(GO:0048687) positive regulation of axon extension involved in regeneration(GO:0048691) modulation by symbiont of host transcription(GO:0052026) |
| 0.2 | 3.8 | GO:0033623 | regulation of integrin activation(GO:0033623) |
| 0.2 | 1.3 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
| 0.2 | 1.3 | GO:0035803 | egg coat formation(GO:0035803) |
| 0.2 | 3.1 | GO:0072307 | metanephric nephron tubule epithelial cell differentiation(GO:0072257) regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072307) |
| 0.2 | 0.8 | GO:0021558 | trochlear nerve development(GO:0021558) |
| 0.2 | 2.1 | GO:0010811 | positive regulation of cell-substrate adhesion(GO:0010811) |
| 0.2 | 4.6 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
| 0.2 | 2.1 | GO:0090324 | negative regulation of oxidative phosphorylation(GO:0090324) |
| 0.2 | 0.6 | GO:0070527 | platelet aggregation(GO:0070527) |
| 0.2 | 1.0 | GO:0042412 | taurine biosynthetic process(GO:0042412) |
| 0.2 | 3.0 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
| 0.2 | 2.2 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
| 0.2 | 1.8 | GO:0019323 | pentose catabolic process(GO:0019323) |
| 0.2 | 4.0 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
| 0.2 | 1.8 | GO:0048664 | neuron fate determination(GO:0048664) |
| 0.2 | 3.2 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
| 0.2 | 1.2 | GO:1904219 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 0.2 | 0.4 | GO:0060133 | somatotropin secreting cell development(GO:0060133) |
| 0.2 | 0.6 | GO:1901253 | negative regulation of intracellular transport of viral material(GO:1901253) |
| 0.2 | 0.6 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
| 0.2 | 8.0 | GO:0010669 | epithelial structure maintenance(GO:0010669) |
| 0.2 | 4.2 | GO:0006590 | thyroid hormone generation(GO:0006590) |
| 0.2 | 1.7 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
| 0.2 | 6.7 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
| 0.2 | 1.9 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
| 0.2 | 0.9 | GO:0000117 | regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0000117) |
| 0.2 | 0.9 | GO:1903974 | mammary gland fat development(GO:0060611) positive regulation of macrophage colony-stimulating factor signaling pathway(GO:1902228) positive regulation of response to macrophage colony-stimulating factor(GO:1903971) positive regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903974) positive regulation of microglial cell migration(GO:1904141) |
| 0.2 | 1.1 | GO:0009799 | specification of symmetry(GO:0009799) |
| 0.2 | 0.6 | GO:0071963 | establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
| 0.2 | 0.7 | GO:0018352 | protein-pyridoxal-5-phosphate linkage(GO:0018352) |
| 0.2 | 3.6 | GO:0019532 | oxalate transport(GO:0019532) |
| 0.2 | 0.2 | GO:0032707 | negative regulation of interleukin-23 production(GO:0032707) |
| 0.2 | 0.7 | GO:0033512 | L-lysine catabolic process to acetyl-CoA via saccharopine(GO:0033512) |
| 0.2 | 12.7 | GO:0035987 | endodermal cell differentiation(GO:0035987) |
| 0.2 | 0.5 | GO:0072361 | regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter(GO:0072361) |
| 0.2 | 0.3 | GO:0014908 | myotube differentiation involved in skeletal muscle regeneration(GO:0014908) |
| 0.2 | 0.2 | GO:0002042 | cell migration involved in sprouting angiogenesis(GO:0002042) |
| 0.2 | 0.5 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
| 0.2 | 0.9 | GO:0030866 | cortical cytoskeleton organization(GO:0030865) cortical actin cytoskeleton organization(GO:0030866) |
| 0.2 | 0.7 | GO:0051552 | flavone metabolic process(GO:0051552) |
| 0.2 | 1.4 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
| 0.2 | 3.5 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
| 0.2 | 1.3 | GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
| 0.2 | 1.8 | GO:0034378 | chylomicron assembly(GO:0034378) |
| 0.2 | 2.3 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
| 0.2 | 6.2 | GO:0006099 | tricarboxylic acid cycle(GO:0006099) |
| 0.2 | 1.6 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
| 0.2 | 1.3 | GO:0060215 | primitive hemopoiesis(GO:0060215) |
| 0.2 | 0.5 | GO:1902356 | thiosulfate transport(GO:0015709) oxaloacetate transport(GO:0015729) malate transport(GO:0015743) malate transmembrane transport(GO:0071423) oxaloacetate(2-) transmembrane transport(GO:1902356) |
| 0.2 | 0.8 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
| 0.2 | 2.3 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
| 0.2 | 0.6 | GO:0018283 | metal incorporation into metallo-sulfur cluster(GO:0018282) iron incorporation into metallo-sulfur cluster(GO:0018283) |
| 0.2 | 1.1 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
| 0.2 | 10.7 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
| 0.2 | 3.6 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
| 0.2 | 0.8 | GO:0009257 | 10-formyltetrahydrofolate biosynthetic process(GO:0009257) |
| 0.2 | 2.5 | GO:0042761 | very long-chain fatty acid biosynthetic process(GO:0042761) |
| 0.2 | 0.8 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
| 0.2 | 0.8 | GO:0045168 | cell-cell signaling involved in cell fate commitment(GO:0045168) |
| 0.2 | 0.9 | GO:0048022 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
| 0.2 | 0.5 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
| 0.2 | 1.2 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
| 0.2 | 2.4 | GO:0060046 | regulation of acrosome reaction(GO:0060046) |
| 0.1 | 0.9 | GO:0002933 | lipid hydroxylation(GO:0002933) |
| 0.1 | 5.0 | GO:0042776 | mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
| 0.1 | 0.6 | GO:0090301 | regulation of neural crest formation(GO:0090299) negative regulation of neural crest formation(GO:0090301) negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000314) |
| 0.1 | 0.9 | GO:0019542 | acetate biosynthetic process(GO:0019413) acetyl-CoA biosynthetic process from acetate(GO:0019427) propionate metabolic process(GO:0019541) propionate biosynthetic process(GO:0019542) |
| 0.1 | 0.4 | GO:0044861 | protein transport into plasma membrane raft(GO:0044861) |
| 0.1 | 2.5 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
| 0.1 | 0.4 | GO:0003095 | pressure natriuresis(GO:0003095) |
| 0.1 | 1.0 | GO:0003402 | planar cell polarity pathway involved in axis elongation(GO:0003402) |
| 0.1 | 1.6 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
| 0.1 | 0.4 | GO:1902871 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) cerebral cortex GABAergic interneuron fate commitment(GO:0021893) positive regulation of neural retina development(GO:0061075) positive regulation of retina development in camera-type eye(GO:1902868) positive regulation of amacrine cell differentiation(GO:1902871) |
| 0.1 | 0.4 | GO:2000354 | regulation of ovarian follicle development(GO:2000354) |
| 0.1 | 0.4 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
| 0.1 | 2.1 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
| 0.1 | 4.3 | GO:0036150 | phosphatidylserine acyl-chain remodeling(GO:0036150) |
| 0.1 | 1.8 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) |
| 0.1 | 0.3 | GO:0046416 | D-amino acid metabolic process(GO:0046416) |
| 0.1 | 0.5 | GO:0006480 | N-terminal protein amino acid methylation(GO:0006480) |
| 0.1 | 0.7 | GO:0018153 | isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine(GO:0018153) isopeptide cross-linking(GO:0018262) |
| 0.1 | 1.4 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
| 0.1 | 0.8 | GO:0098886 | modification of dendritic spine(GO:0098886) |
| 0.1 | 1.7 | GO:0031033 | myosin filament organization(GO:0031033) |
| 0.1 | 1.0 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
| 0.1 | 0.6 | GO:0097475 | motor neuron migration(GO:0097475) |
| 0.1 | 0.5 | GO:0032849 | positive regulation of cellular pH reduction(GO:0032849) |
| 0.1 | 2.3 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
| 0.1 | 1.5 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
| 0.1 | 1.5 | GO:0060056 | mammary gland involution(GO:0060056) |
| 0.1 | 1.6 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
| 0.1 | 0.6 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
| 0.1 | 2.0 | GO:0016576 | histone dephosphorylation(GO:0016576) |
| 0.1 | 1.8 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
| 0.1 | 0.2 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
| 0.1 | 0.8 | GO:0021590 | cerebellum maturation(GO:0021590) cerebellar cortex maturation(GO:0021699) |
| 0.1 | 0.8 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
| 0.1 | 0.4 | GO:0097198 | histone H3-K36 trimethylation(GO:0097198) |
| 0.1 | 1.4 | GO:2000291 | regulation of myoblast proliferation(GO:2000291) |
| 0.1 | 5.2 | GO:0032958 | inositol phosphate biosynthetic process(GO:0032958) |
| 0.1 | 0.4 | GO:0018312 | peptidyl-serine ADP-ribosylation(GO:0018312) |
| 0.1 | 0.6 | GO:0097192 | signal transduction in absence of ligand(GO:0038034) extrinsic apoptotic signaling pathway in absence of ligand(GO:0097192) |
| 0.1 | 6.7 | GO:0030049 | muscle filament sliding(GO:0030049) actin-myosin filament sliding(GO:0033275) |
| 0.1 | 0.4 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
| 0.1 | 0.9 | GO:0007320 | insemination(GO:0007320) |
| 0.1 | 0.6 | GO:1900039 | positive regulation of cellular response to hypoxia(GO:1900039) |
| 0.1 | 0.4 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
| 0.1 | 2.1 | GO:1902600 | hydrogen ion transmembrane transport(GO:1902600) |
| 0.1 | 1.1 | GO:0033673 | negative regulation of protein kinase activity(GO:0006469) negative regulation of kinase activity(GO:0033673) |
| 0.1 | 0.7 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
| 0.1 | 0.3 | GO:0040009 | regulation of growth rate(GO:0040009) |
| 0.1 | 3.5 | GO:0051764 | actin crosslink formation(GO:0051764) |
| 0.1 | 2.0 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
| 0.1 | 2.4 | GO:0045725 | positive regulation of glycogen biosynthetic process(GO:0045725) |
| 0.1 | 1.0 | GO:0071799 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
| 0.1 | 0.7 | GO:0055129 | L-proline biosynthetic process(GO:0055129) |
| 0.1 | 1.6 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
| 0.1 | 0.9 | GO:0033007 | negative regulation of mast cell activation involved in immune response(GO:0033007) negative regulation of mast cell degranulation(GO:0043305) |
| 0.1 | 2.1 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
| 0.1 | 0.3 | GO:0001579 | medium-chain fatty acid transport(GO:0001579) |
| 0.1 | 0.7 | GO:0032185 | septin cytoskeleton organization(GO:0032185) |
| 0.1 | 2.1 | GO:0016540 | protein autoprocessing(GO:0016540) |
| 0.1 | 0.6 | GO:0090190 | positive regulation of branching involved in ureteric bud morphogenesis(GO:0090190) |
| 0.1 | 1.9 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
| 0.1 | 0.3 | GO:0070676 | intralumenal vesicle formation(GO:0070676) |
| 0.1 | 0.4 | GO:0042369 | vitamin D catabolic process(GO:0042369) |
| 0.1 | 0.4 | GO:0051710 | cytolysis by symbiont of host cells(GO:0001897) negative regulation of cytolysis(GO:0045918) regulation of cytolysis in other organism(GO:0051710) |
| 0.1 | 0.6 | GO:0060005 | vestibular reflex(GO:0060005) |
| 0.1 | 2.2 | GO:0010226 | response to lithium ion(GO:0010226) |
| 0.1 | 0.6 | GO:0002803 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) positive regulation of antibacterial peptide production(GO:0002803) |
| 0.1 | 0.9 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
| 0.1 | 0.9 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
| 0.1 | 3.6 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 0.1 | 2.6 | GO:0046320 | regulation of fatty acid oxidation(GO:0046320) |
| 0.1 | 0.3 | GO:0060370 | susceptibility to T cell mediated cytotoxicity(GO:0060370) |
| 0.1 | 0.7 | GO:0097461 | ferric iron import into cell(GO:0097461) ferric iron import across plasma membrane(GO:0098706) |
| 0.1 | 0.2 | GO:0006473 | protein acetylation(GO:0006473) |
| 0.1 | 0.5 | GO:0060481 | lobar bronchus epithelium development(GO:0060481) |
| 0.1 | 0.4 | GO:1902766 | skeletal muscle satellite cell migration(GO:1902766) |
| 0.1 | 0.8 | GO:0006953 | acute-phase response(GO:0006953) |
| 0.1 | 0.1 | GO:0032425 | regulation of mismatch repair(GO:0032423) positive regulation of mismatch repair(GO:0032425) |
| 0.1 | 2.6 | GO:0000038 | very long-chain fatty acid metabolic process(GO:0000038) |
| 0.1 | 1.8 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
| 0.1 | 0.4 | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
| 0.1 | 0.6 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
| 0.1 | 0.3 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
| 0.1 | 2.2 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
| 0.1 | 1.5 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
| 0.1 | 1.1 | GO:0071907 | determination of digestive tract left/right asymmetry(GO:0071907) |
| 0.1 | 2.2 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
| 0.1 | 0.5 | GO:0033490 | cholesterol biosynthetic process via desmosterol(GO:0033489) cholesterol biosynthetic process via lathosterol(GO:0033490) |
| 0.1 | 0.4 | GO:0031214 | biomineral tissue development(GO:0031214) |
| 0.1 | 1.0 | GO:1902001 | fatty acid transmembrane transport(GO:1902001) |
| 0.1 | 1.1 | GO:0030259 | lipid glycosylation(GO:0030259) |
| 0.1 | 1.9 | GO:0001893 | maternal placenta development(GO:0001893) |
| 0.1 | 0.3 | GO:0051715 | cytolysis in other organism(GO:0051715) |
| 0.1 | 0.5 | GO:0060013 | righting reflex(GO:0060013) |
| 0.1 | 0.3 | GO:0061727 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
| 0.1 | 0.6 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
| 0.1 | 1.8 | GO:0032060 | bleb assembly(GO:0032060) |
| 0.1 | 1.2 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
| 0.1 | 0.5 | GO:0015811 | L-cystine transport(GO:0015811) |
| 0.1 | 3.1 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
| 0.1 | 0.4 | GO:0001919 | regulation of receptor recycling(GO:0001919) |
| 0.1 | 0.5 | GO:1900063 | regulation of peroxisome organization(GO:1900063) |
| 0.1 | 0.7 | GO:0072189 | ureter development(GO:0072189) |
| 0.1 | 0.7 | GO:1990822 | basic amino acid transmembrane transport(GO:1990822) |
| 0.1 | 0.3 | GO:0046950 | cellular ketone body metabolic process(GO:0046950) ketone body catabolic process(GO:0046952) |
| 0.1 | 0.3 | GO:2000416 | regulation of eosinophil migration(GO:2000416) positive regulation of eosinophil migration(GO:2000418) |
| 0.1 | 2.3 | GO:0046688 | response to copper ion(GO:0046688) |
| 0.1 | 0.3 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
| 0.1 | 4.7 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
| 0.1 | 3.8 | GO:0005980 | glycogen catabolic process(GO:0005980) |
| 0.1 | 1.0 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
| 0.1 | 0.3 | GO:0030222 | eosinophil differentiation(GO:0030222) |
| 0.1 | 1.9 | GO:0002021 | response to dietary excess(GO:0002021) |
| 0.1 | 0.3 | GO:0046909 | intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
| 0.1 | 1.8 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
| 0.1 | 0.7 | GO:0045907 | positive regulation of vasoconstriction(GO:0045907) |
| 0.1 | 0.5 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
| 0.1 | 0.7 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
| 0.1 | 1.3 | GO:2001197 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
| 0.1 | 0.7 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
| 0.1 | 1.4 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
| 0.1 | 5.2 | GO:0035914 | skeletal muscle cell differentiation(GO:0035914) |
| 0.1 | 1.1 | GO:0032098 | regulation of appetite(GO:0032098) |
| 0.1 | 0.7 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
| 0.1 | 2.5 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
| 0.1 | 0.5 | GO:0019918 | peptidyl-arginine methylation, to symmetrical-dimethyl arginine(GO:0019918) |
| 0.1 | 0.4 | GO:0061107 | seminal vesicle development(GO:0061107) |
| 0.1 | 1.2 | GO:0071850 | mitotic cell cycle arrest(GO:0071850) |
| 0.1 | 0.5 | GO:0044565 | dendritic cell proliferation(GO:0044565) |
| 0.1 | 1.8 | GO:0022011 | myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
| 0.1 | 0.3 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
| 0.1 | 0.3 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) |
| 0.1 | 0.7 | GO:0051026 | chiasma assembly(GO:0051026) |
| 0.1 | 1.2 | GO:0050872 | white fat cell differentiation(GO:0050872) |
| 0.1 | 0.4 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
| 0.1 | 0.5 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
| 0.1 | 0.2 | GO:0035606 | peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
| 0.1 | 1.4 | GO:0003334 | keratinocyte development(GO:0003334) |
| 0.1 | 4.2 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
| 0.1 | 0.7 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
| 0.1 | 0.6 | GO:0021692 | cerebellar Purkinje cell layer morphogenesis(GO:0021692) |
| 0.1 | 0.3 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
| 0.1 | 0.3 | GO:0002143 | tRNA wobble position uridine thiolation(GO:0002143) |
| 0.1 | 0.4 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
| 0.1 | 0.3 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
| 0.1 | 0.8 | GO:0070327 | thyroid hormone transport(GO:0070327) |
| 0.1 | 1.9 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
| 0.1 | 0.2 | GO:0080120 | prenylated protein catabolic process(GO:0030327) CAAX-box protein processing(GO:0071586) CAAX-box protein maturation(GO:0080120) |
| 0.1 | 1.1 | GO:0060571 | morphogenesis of an epithelial fold(GO:0060571) |
| 0.1 | 0.5 | GO:0072501 | cellular phosphate ion homeostasis(GO:0030643) cellular divalent inorganic anion homeostasis(GO:0072501) cellular trivalent inorganic anion homeostasis(GO:0072502) |
| 0.1 | 0.4 | GO:2000619 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) negative regulation of histone H4-K16 acetylation(GO:2000619) |
| 0.1 | 2.1 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
| 0.1 | 0.1 | GO:0070459 | prolactin secretion(GO:0070459) |
| 0.1 | 0.3 | GO:0035754 | B cell chemotaxis(GO:0035754) |
| 0.1 | 1.5 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
| 0.1 | 0.1 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) activation of protein kinase C activity(GO:1990051) |
| 0.1 | 3.3 | GO:0015701 | bicarbonate transport(GO:0015701) |
| 0.1 | 1.2 | GO:0046710 | GDP metabolic process(GO:0046710) |
| 0.1 | 0.1 | GO:0090135 | actin filament branching(GO:0090135) |
| 0.1 | 1.3 | GO:0006768 | biotin metabolic process(GO:0006768) |
| 0.1 | 1.4 | GO:0045214 | sarcomere organization(GO:0045214) |
| 0.1 | 0.4 | GO:0061767 | negative regulation of lung blood pressure(GO:0061767) |
| 0.1 | 1.6 | GO:0097031 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
| 0.1 | 0.5 | GO:0097577 | intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
| 0.1 | 0.3 | GO:0008589 | regulation of smoothened signaling pathway(GO:0008589) |
| 0.1 | 1.2 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
| 0.1 | 0.5 | GO:1903244 | positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) |
| 0.1 | 2.4 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
| 0.1 | 0.7 | GO:0031100 | organ regeneration(GO:0031100) |
| 0.1 | 4.2 | GO:0030574 | collagen catabolic process(GO:0030574) |
| 0.1 | 1.0 | GO:0000338 | protein deneddylation(GO:0000338) |
| 0.1 | 0.2 | GO:0038030 | non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
| 0.1 | 0.6 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
| 0.1 | 0.2 | GO:1903301 | positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
| 0.1 | 0.3 | GO:0010636 | positive regulation of mitochondrial fusion(GO:0010636) |
| 0.1 | 0.3 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
| 0.1 | 0.3 | GO:0035026 | leading edge cell differentiation(GO:0035026) |
| 0.1 | 0.4 | GO:0035166 | post-embryonic hemopoiesis(GO:0035166) |
| 0.1 | 0.8 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
| 0.1 | 0.1 | GO:0035669 | TRAM-dependent toll-like receptor signaling pathway(GO:0035668) TRAM-dependent toll-like receptor 4 signaling pathway(GO:0035669) |
| 0.1 | 0.3 | GO:0048659 | smooth muscle cell proliferation(GO:0048659) |
| 0.1 | 2.2 | GO:0051931 | regulation of sensory perception of pain(GO:0051930) regulation of sensory perception(GO:0051931) |
| 0.1 | 1.3 | GO:0071276 | cellular response to cadmium ion(GO:0071276) |
| 0.1 | 2.7 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
| 0.1 | 0.8 | GO:0035878 | nail development(GO:0035878) |
| 0.1 | 1.7 | GO:0071625 | vocalization behavior(GO:0071625) |
| 0.1 | 1.2 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
| 0.1 | 0.7 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
| 0.1 | 1.9 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
| 0.1 | 0.7 | GO:0030091 | protein repair(GO:0030091) |
| 0.1 | 0.7 | GO:0006089 | lactate metabolic process(GO:0006089) |
| 0.1 | 0.7 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
| 0.1 | 0.6 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
| 0.1 | 0.2 | GO:0009236 | cobalamin biosynthetic process(GO:0009236) |
| 0.1 | 0.2 | GO:2000395 | regulation of ubiquitin-dependent endocytosis(GO:2000395) positive regulation of ubiquitin-dependent endocytosis(GO:2000397) |
| 0.1 | 0.9 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
| 0.1 | 0.1 | GO:0006338 | chromatin remodeling(GO:0006338) |
| 0.1 | 0.9 | GO:0021814 | cell motility involved in cerebral cortex radial glia guided migration(GO:0021814) |
| 0.1 | 1.2 | GO:0030252 | growth hormone secretion(GO:0030252) |
| 0.1 | 0.7 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 0.1 | 1.5 | GO:1903963 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
| 0.0 | 0.1 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
| 0.0 | 0.4 | GO:0060325 | face morphogenesis(GO:0060325) |
| 0.0 | 1.1 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
| 0.0 | 0.3 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
| 0.0 | 0.3 | GO:0007097 | nuclear migration(GO:0007097) |
| 0.0 | 0.4 | GO:0032092 | positive regulation of protein binding(GO:0032092) |
| 0.0 | 1.0 | GO:0010745 | negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
| 0.0 | 6.0 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
| 0.0 | 1.0 | GO:0052312 | modulation of transcription in other organism involved in symbiotic interaction(GO:0052312) |
| 0.0 | 1.2 | GO:2000404 | regulation of T cell migration(GO:2000404) |
| 0.0 | 3.0 | GO:0006937 | regulation of muscle contraction(GO:0006937) |
| 0.0 | 0.7 | GO:0015886 | heme transport(GO:0015886) |
| 0.0 | 0.7 | GO:0006119 | oxidative phosphorylation(GO:0006119) |
| 0.0 | 0.1 | GO:0032096 | negative regulation of response to food(GO:0032096) negative regulation of appetite(GO:0032099) |
| 0.0 | 1.3 | GO:0038084 | vascular endothelial growth factor signaling pathway(GO:0038084) |
| 0.0 | 0.3 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
| 0.0 | 0.3 | GO:0090493 | dopamine uptake involved in synaptic transmission(GO:0051583) catecholamine uptake involved in synaptic transmission(GO:0051934) catecholamine uptake(GO:0090493) dopamine uptake(GO:0090494) |
| 0.0 | 0.3 | GO:0045008 | depyrimidination(GO:0045008) |
| 0.0 | 3.4 | GO:0050909 | sensory perception of taste(GO:0050909) |
| 0.0 | 0.7 | GO:2000651 | positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
| 0.0 | 0.8 | GO:0010765 | positive regulation of sodium ion transport(GO:0010765) |
| 0.0 | 0.4 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
| 0.0 | 0.9 | GO:1900364 | negative regulation of mRNA polyadenylation(GO:1900364) |
| 0.0 | 0.2 | GO:0002034 | regulation of blood vessel size by renin-angiotensin(GO:0002034) renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure(GO:0003072) |
| 0.0 | 1.1 | GO:0060384 | innervation(GO:0060384) |
| 0.0 | 1.4 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
| 0.0 | 0.2 | GO:0031508 | pericentric heterochromatin assembly(GO:0031508) |
| 0.0 | 0.2 | GO:0050773 | regulation of dendrite development(GO:0050773) |
| 0.0 | 2.6 | GO:0015949 | nucleobase-containing small molecule interconversion(GO:0015949) |
| 0.0 | 0.1 | GO:1900075 | regulation of neuromuscular synaptic transmission(GO:1900073) positive regulation of neuromuscular synaptic transmission(GO:1900075) |
| 0.0 | 4.7 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
| 0.0 | 0.1 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
| 0.0 | 0.5 | GO:0042118 | endothelial cell activation(GO:0042118) |
| 0.0 | 0.1 | GO:2000744 | anterior head development(GO:0097065) regulation of anterior head development(GO:2000742) positive regulation of anterior head development(GO:2000744) |
| 0.0 | 0.5 | GO:0008595 | tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
| 0.0 | 0.8 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
| 0.0 | 0.3 | GO:0070444 | oligodendrocyte progenitor proliferation(GO:0070444) regulation of oligodendrocyte progenitor proliferation(GO:0070445) |
| 0.0 | 0.6 | GO:1901642 | nucleoside transmembrane transport(GO:1901642) |
| 0.0 | 0.1 | GO:0045226 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
| 0.0 | 0.8 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
| 0.0 | 0.6 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
| 0.0 | 0.4 | GO:0061081 | positive regulation of macrophage cytokine production(GO:0060907) positive regulation of myeloid leukocyte cytokine production involved in immune response(GO:0061081) |
| 0.0 | 0.6 | GO:0035640 | exploration behavior(GO:0035640) |
| 0.0 | 0.1 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
| 0.0 | 1.7 | GO:0008089 | anterograde axonal transport(GO:0008089) |
| 0.0 | 0.8 | GO:0046415 | urate metabolic process(GO:0046415) |
| 0.0 | 0.8 | GO:0032354 | response to follicle-stimulating hormone(GO:0032354) |
| 0.0 | 0.2 | GO:0060754 | positive regulation of mast cell chemotaxis(GO:0060754) |
| 0.0 | 0.4 | GO:0015985 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
| 0.0 | 0.2 | GO:0015742 | alpha-ketoglutarate transport(GO:0015742) |
| 0.0 | 0.1 | GO:0009644 | response to high light intensity(GO:0009644) |
| 0.0 | 1.7 | GO:1901379 | regulation of potassium ion transmembrane transport(GO:1901379) |
| 0.0 | 0.1 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
| 0.0 | 1.1 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
| 0.0 | 0.5 | GO:1904896 | ESCRT complex disassembly(GO:1904896) ESCRT III complex disassembly(GO:1904903) |
| 0.0 | 0.5 | GO:0030325 | adrenal gland development(GO:0030325) |
| 0.0 | 1.0 | GO:0031954 | positive regulation of protein autophosphorylation(GO:0031954) |
| 0.0 | 0.6 | GO:0071300 | cellular response to retinoic acid(GO:0071300) |
| 0.0 | 0.5 | GO:0032790 | ribosome disassembly(GO:0032790) |
| 0.0 | 0.1 | GO:0035522 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
| 0.0 | 0.7 | GO:0006558 | L-phenylalanine metabolic process(GO:0006558) L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
| 0.0 | 0.2 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
| 0.0 | 6.5 | GO:0006813 | potassium ion transport(GO:0006813) |
| 0.0 | 0.3 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
| 0.0 | 0.1 | GO:0032627 | interleukin-23 production(GO:0032627) regulation of interleukin-23 production(GO:0032667) positive regulation of interleukin-23 production(GO:0032747) |
| 0.0 | 0.1 | GO:1900368 | pre-miRNA export from nucleus(GO:0035281) regulation of RNA interference(GO:1900368) |
| 0.0 | 0.4 | GO:1900078 | positive regulation of cellular response to insulin stimulus(GO:1900078) |
| 0.0 | 1.2 | GO:0002028 | regulation of sodium ion transport(GO:0002028) |
| 0.0 | 0.6 | GO:1901748 | leukotriene D4 metabolic process(GO:1901748) leukotriene D4 biosynthetic process(GO:1901750) |
| 0.0 | 0.6 | GO:0051496 | positive regulation of stress fiber assembly(GO:0051496) |
| 0.0 | 0.7 | GO:0014002 | astrocyte development(GO:0014002) |
| 0.0 | 0.5 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
| 0.0 | 0.2 | GO:0050684 | regulation of mRNA processing(GO:0050684) |
| 0.0 | 0.3 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
| 0.0 | 0.2 | GO:0016584 | nucleosome positioning(GO:0016584) |
| 0.0 | 0.8 | GO:0045744 | negative regulation of G-protein coupled receptor protein signaling pathway(GO:0045744) |
| 0.0 | 0.5 | GO:0060441 | epithelial tube branching involved in lung morphogenesis(GO:0060441) |
| 0.0 | 1.9 | GO:0006941 | striated muscle contraction(GO:0006941) |
| 0.0 | 0.2 | GO:0018343 | protein farnesylation(GO:0018343) |
| 0.0 | 0.2 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
| 0.0 | 0.6 | GO:0048713 | regulation of oligodendrocyte differentiation(GO:0048713) |
| 0.0 | 1.0 | GO:0044381 | glucose import in response to insulin stimulus(GO:0044381) |
| 0.0 | 3.0 | GO:0016266 | O-glycan processing(GO:0016266) |
| 0.0 | 0.7 | GO:0017156 | calcium ion regulated exocytosis(GO:0017156) |
| 0.0 | 2.3 | GO:0006939 | smooth muscle contraction(GO:0006939) |
| 0.0 | 0.1 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
| 0.0 | 0.5 | GO:0006828 | manganese ion transport(GO:0006828) |
| 0.0 | 0.3 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
| 0.0 | 0.2 | GO:0019236 | response to pheromone(GO:0019236) |
| 0.0 | 2.3 | GO:0001523 | retinoid metabolic process(GO:0001523) |
| 0.0 | 1.3 | GO:0003281 | ventricular septum development(GO:0003281) |
| 0.0 | 0.3 | GO:0006782 | protoporphyrinogen IX biosynthetic process(GO:0006782) |
| 0.0 | 1.1 | GO:0010039 | response to iron ion(GO:0010039) |
| 0.0 | 0.2 | GO:0006824 | cobalt ion transport(GO:0006824) |
| 0.0 | 0.3 | GO:0035897 | proteolysis in other organism(GO:0035897) |
| 0.0 | 0.2 | GO:0000422 | mitophagy(GO:0000422) mitochondrion disassembly(GO:0061726) |
| 0.0 | 1.2 | GO:0014003 | oligodendrocyte development(GO:0014003) |
| 0.0 | 0.4 | GO:0006783 | heme biosynthetic process(GO:0006783) |
| 0.0 | 0.5 | GO:0042749 | regulation of circadian sleep/wake cycle(GO:0042749) regulation of circadian sleep/wake cycle, sleep(GO:0045187) |
| 0.0 | 0.6 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
| 0.0 | 0.3 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
| 0.0 | 0.1 | GO:0051918 | regulation of fibrinolysis(GO:0051917) negative regulation of fibrinolysis(GO:0051918) |
| 0.0 | 0.2 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
| 0.0 | 1.3 | GO:0018208 | peptidyl-proline modification(GO:0018208) |
| 0.0 | 0.2 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
| 0.0 | 0.2 | GO:0090175 | Wnt signaling pathway, planar cell polarity pathway(GO:0060071) regulation of establishment of planar polarity(GO:0090175) |
| 0.0 | 0.1 | GO:0006742 | NADP catabolic process(GO:0006742) pyridine nucleotide catabolic process(GO:0019364) |
| 0.0 | 0.8 | GO:0099601 | regulation of neurotransmitter receptor activity(GO:0099601) |
| 0.0 | 0.4 | GO:0090343 | positive regulation of cell aging(GO:0090343) positive regulation of cellular senescence(GO:2000774) |
| 0.0 | 0.1 | GO:0000270 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
| 0.0 | 0.5 | GO:0035249 | synaptic transmission, glutamatergic(GO:0035249) |
| 0.0 | 0.4 | GO:0050951 | sensory perception of temperature stimulus(GO:0050951) |
| 0.0 | 1.0 | GO:0008206 | bile acid metabolic process(GO:0008206) |
| 0.0 | 1.3 | GO:0035825 | reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
| 0.0 | 0.1 | GO:0035494 | SNARE complex disassembly(GO:0035494) |
| 0.0 | 0.2 | GO:0046398 | UDP-glucuronate biosynthetic process(GO:0006065) UDP-glucuronate metabolic process(GO:0046398) |
| 0.0 | 0.6 | GO:0006744 | ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
| 0.0 | 1.0 | GO:0000060 | protein import into nucleus, translocation(GO:0000060) |
| 0.0 | 0.4 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
| 0.0 | 0.4 | GO:0006919 | activation of cysteine-type endopeptidase activity involved in apoptotic process(GO:0006919) |
| 0.0 | 0.0 | GO:1902990 | mitotic telomere maintenance via semi-conservative replication(GO:1902990) |
| 0.0 | 0.3 | GO:0052695 | cellular glucuronidation(GO:0052695) |
| 0.0 | 0.2 | GO:0034629 | cellular protein complex localization(GO:0034629) exocyst localization(GO:0051601) |
| 0.0 | 0.1 | GO:0061760 | antifungal innate immune response(GO:0061760) |
| 0.0 | 0.2 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
| 0.0 | 0.1 | GO:0002159 | desmosome assembly(GO:0002159) |
| 0.0 | 0.4 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
| 0.0 | 0.3 | GO:0072655 | establishment of protein localization to mitochondrion(GO:0072655) |
| 0.0 | 0.3 | GO:0007340 | acrosome reaction(GO:0007340) |
| 0.0 | 0.5 | GO:0031016 | pancreas development(GO:0031016) |
| 0.0 | 0.0 | GO:0051177 | meiotic sister chromatid cohesion(GO:0051177) |
| 0.0 | 0.9 | GO:0006509 | membrane protein ectodomain proteolysis(GO:0006509) |
| 0.0 | 0.1 | GO:0046825 | regulation of protein export from nucleus(GO:0046825) |
| 0.0 | 0.1 | GO:0035608 | protein deglutamylation(GO:0035608) |
| 0.0 | 0.2 | GO:0032785 | negative regulation of DNA-templated transcription, elongation(GO:0032785) negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
| 0.0 | 2.5 | GO:0070268 | cornification(GO:0070268) |
| 0.0 | 0.2 | GO:2000134 | negative regulation of G1/S transition of mitotic cell cycle(GO:2000134) |
| 0.0 | 0.1 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
| 0.0 | 0.7 | GO:0030048 | actin filament-based movement(GO:0030048) |
| 0.0 | 0.2 | GO:0015858 | nucleoside transport(GO:0015858) |
| 0.0 | 3.9 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
| 0.0 | 5.6 | GO:0030198 | extracellular matrix organization(GO:0030198) |
| 0.0 | 0.5 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
| 0.0 | 0.1 | GO:0010771 | negative regulation of cell morphogenesis involved in differentiation(GO:0010771) |
| 0.0 | 0.1 | GO:0032496 | response to molecule of bacterial origin(GO:0002237) response to lipopolysaccharide(GO:0032496) |
| 0.0 | 0.1 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 0.0 | 0.3 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
| 0.0 | 0.1 | GO:0031116 | positive regulation of microtubule polymerization or depolymerization(GO:0031112) positive regulation of microtubule polymerization(GO:0031116) |
| 0.0 | 0.1 | GO:0060736 | prostate gland growth(GO:0060736) |
| 0.0 | 0.4 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
| 0.0 | 0.1 | GO:1990564 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
| 0.0 | 0.4 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
| 0.0 | 0.1 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
| 0.0 | 0.2 | GO:0030207 | chondroitin sulfate catabolic process(GO:0030207) |
| 0.0 | 0.2 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
| 0.0 | 3.2 | GO:0007517 | muscle organ development(GO:0007517) |
| 0.0 | 0.1 | GO:0051168 | nuclear export(GO:0051168) |
| 0.0 | 4.0 | GO:0006836 | neurotransmitter transport(GO:0006836) |
| 0.0 | 0.3 | GO:0030501 | positive regulation of bone mineralization(GO:0030501) |
| 0.0 | 4.1 | GO:0007608 | sensory perception of smell(GO:0007608) |
| 0.0 | 0.1 | GO:0001928 | regulation of exocyst assembly(GO:0001928) regulation of exocyst localization(GO:0060178) |
| 0.0 | 1.6 | GO:0001578 | microtubule bundle formation(GO:0001578) |
| 0.0 | 0.2 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
| 0.0 | 0.1 | GO:0002176 | male germ cell proliferation(GO:0002176) germ cell proliferation(GO:0036093) |
| 0.0 | 0.6 | GO:0045739 | positive regulation of DNA repair(GO:0045739) |
| 0.0 | 0.5 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
| 0.0 | 0.1 | GO:0042596 | behavioral fear response(GO:0001662) behavioral defense response(GO:0002209) fear response(GO:0042596) |
| 0.0 | 0.1 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
| 0.0 | 0.6 | GO:0042552 | myelination(GO:0042552) |
| 0.0 | 0.5 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
| 0.0 | 1.2 | GO:0001764 | neuron migration(GO:0001764) |
| 0.0 | 0.1 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 0.0 | 0.4 | GO:0032784 | regulation of DNA-templated transcription, elongation(GO:0032784) |
| 0.0 | 0.3 | GO:0090311 | regulation of protein deacetylation(GO:0090311) |
| 0.0 | 0.6 | GO:0006734 | NADH metabolic process(GO:0006734) |
| 0.0 | 0.1 | GO:0035308 | negative regulation of dephosphorylation(GO:0035305) negative regulation of protein dephosphorylation(GO:0035308) |
| 0.0 | 0.9 | GO:0051865 | protein autoubiquitination(GO:0051865) |
| 0.0 | 0.2 | GO:0018210 | peptidyl-threonine modification(GO:0018210) |
| 0.0 | 0.5 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
| 0.0 | 0.5 | GO:1900034 | regulation of cellular response to heat(GO:1900034) |
| 0.0 | 0.8 | GO:0031424 | keratinization(GO:0031424) |
| 0.0 | 0.2 | GO:0007616 | long-term memory(GO:0007616) |
| 0.0 | 0.1 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
| 0.0 | 0.1 | GO:0060749 | mammary gland alveolus development(GO:0060749) mammary gland lobule development(GO:0061377) |
| 0.0 | 0.0 | GO:2000866 | positive regulation of estrogen secretion(GO:2000863) positive regulation of estradiol secretion(GO:2000866) |
| 0.0 | 0.0 | GO:0001881 | receptor recycling(GO:0001881) |
| 0.0 | 0.2 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
| 0.0 | 0.1 | GO:0006833 | water transport(GO:0006833) |
Gene overrepresentation in cellular_component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.7 | 5.0 | GO:0043257 | laminin-8 complex(GO:0043257) |
| 1.6 | 4.7 | GO:0036117 | hyaluranon cable(GO:0036117) |
| 1.3 | 6.7 | GO:0005602 | complement component C1 complex(GO:0005602) |
| 1.2 | 7.4 | GO:0005927 | muscle tendon junction(GO:0005927) |
| 1.1 | 16.4 | GO:0098647 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
| 0.9 | 17.0 | GO:0097512 | cardiac myofibril(GO:0097512) |
| 0.9 | 2.7 | GO:0005595 | collagen type XII trimer(GO:0005595) |
| 0.9 | 2.6 | GO:0043159 | acrosomal matrix(GO:0043159) |
| 0.8 | 13.5 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
| 0.8 | 2.4 | GO:0020003 | symbiont-containing vacuole(GO:0020003) symbiont-containing vacuole membrane(GO:0020005) |
| 0.7 | 1.3 | GO:0030934 | anchoring collagen complex(GO:0030934) |
| 0.7 | 2.0 | GO:0044299 | C-fiber(GO:0044299) |
| 0.6 | 17.3 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
| 0.5 | 6.1 | GO:0016013 | syntrophin complex(GO:0016013) |
| 0.5 | 3.6 | GO:0044326 | dendritic spine neck(GO:0044326) |
| 0.5 | 5.1 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
| 0.5 | 3.4 | GO:0030314 | junctional membrane complex(GO:0030314) |
| 0.5 | 3.7 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
| 0.5 | 1.4 | GO:1990622 | CHOP-ATF3 complex(GO:1990622) |
| 0.4 | 0.9 | GO:0005606 | laminin-1 complex(GO:0005606) |
| 0.4 | 2.1 | GO:1902937 | inward rectifier potassium channel complex(GO:1902937) |
| 0.4 | 14.9 | GO:0031527 | filopodium membrane(GO:0031527) |
| 0.4 | 1.2 | GO:0034684 | integrin alphav-beta5 complex(GO:0034684) |
| 0.4 | 6.9 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
| 0.4 | 1.1 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
| 0.4 | 1.5 | GO:0045257 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
| 0.4 | 2.5 | GO:0005899 | insulin receptor complex(GO:0005899) |
| 0.3 | 6.2 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
| 0.3 | 2.8 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
| 0.3 | 10.3 | GO:0005614 | interstitial matrix(GO:0005614) |
| 0.3 | 18.4 | GO:0031430 | M band(GO:0031430) |
| 0.3 | 3.5 | GO:0032009 | early phagosome(GO:0032009) |
| 0.3 | 1.7 | GO:0045272 | plasma membrane respiratory chain complex I(GO:0045272) plasma membrane respiratory chain(GO:0070470) |
| 0.3 | 1.7 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
| 0.3 | 2.3 | GO:0005587 | collagen type IV trimer(GO:0005587) |
| 0.3 | 6.7 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
| 0.2 | 2.5 | GO:0005579 | membrane attack complex(GO:0005579) |
| 0.2 | 0.7 | GO:0005588 | collagen type V trimer(GO:0005588) |
| 0.2 | 2.5 | GO:0005610 | laminin-5 complex(GO:0005610) |
| 0.2 | 2.5 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
| 0.2 | 2.9 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
| 0.2 | 1.1 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
| 0.2 | 5.4 | GO:0005859 | muscle myosin complex(GO:0005859) |
| 0.2 | 2.6 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
| 0.2 | 3.7 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
| 0.2 | 6.6 | GO:0005605 | basal lamina(GO:0005605) |
| 0.2 | 1.8 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
| 0.2 | 1.4 | GO:0061617 | MICOS complex(GO:0061617) |
| 0.2 | 0.7 | GO:0032437 | cuticular plate(GO:0032437) |
| 0.2 | 0.9 | GO:0032449 | CBM complex(GO:0032449) |
| 0.2 | 6.9 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
| 0.2 | 3.7 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
| 0.2 | 0.3 | GO:1990584 | cardiac Troponin complex(GO:1990584) |
| 0.2 | 4.0 | GO:0043203 | axon hillock(GO:0043203) |
| 0.2 | 0.5 | GO:0005745 | m-AAA complex(GO:0005745) |
| 0.2 | 1.2 | GO:1990130 | Iml1 complex(GO:1990130) |
| 0.2 | 1.8 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
| 0.2 | 2.4 | GO:0030478 | actin cap(GO:0030478) |
| 0.2 | 33.6 | GO:0030018 | Z disc(GO:0030018) |
| 0.2 | 6.5 | GO:0002080 | acrosomal membrane(GO:0002080) |
| 0.2 | 12.6 | GO:0030017 | sarcomere(GO:0030017) |
| 0.2 | 5.6 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
| 0.1 | 1.2 | GO:0070695 | FHF complex(GO:0070695) |
| 0.1 | 0.6 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
| 0.1 | 0.6 | GO:0070931 | Golgi-associated vesicle lumen(GO:0070931) |
| 0.1 | 0.7 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
| 0.1 | 2.4 | GO:0036449 | microtubule minus-end(GO:0036449) |
| 0.1 | 0.8 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
| 0.1 | 3.5 | GO:0001527 | microfibril(GO:0001527) fibril(GO:0043205) |
| 0.1 | 1.4 | GO:0097442 | CA3 pyramidal cell dendrite(GO:0097442) |
| 0.1 | 0.6 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
| 0.1 | 1.2 | GO:0061574 | ASAP complex(GO:0061574) |
| 0.1 | 1.1 | GO:0030658 | transport vesicle membrane(GO:0030658) |
| 0.1 | 2.1 | GO:0000815 | ESCRT III complex(GO:0000815) |
| 0.1 | 1.8 | GO:0033268 | node of Ranvier(GO:0033268) |
| 0.1 | 7.6 | GO:0030964 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
| 0.1 | 2.6 | GO:0031305 | intrinsic component of mitochondrial inner membrane(GO:0031304) integral component of mitochondrial inner membrane(GO:0031305) |
| 0.1 | 1.1 | GO:0016012 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
| 0.1 | 0.9 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
| 0.1 | 1.4 | GO:0008091 | spectrin(GO:0008091) |
| 0.1 | 6.1 | GO:0008305 | integrin complex(GO:0008305) |
| 0.1 | 1.3 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
| 0.1 | 14.3 | GO:0005796 | Golgi lumen(GO:0005796) |
| 0.1 | 0.3 | GO:0000779 | condensed chromosome kinetochore(GO:0000777) condensed chromosome, centromeric region(GO:0000779) |
| 0.1 | 3.7 | GO:0005921 | gap junction(GO:0005921) |
| 0.1 | 0.6 | GO:0097209 | epidermal lamellar body(GO:0097209) |
| 0.1 | 0.4 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
| 0.1 | 0.3 | GO:0038038 | G-protein coupled receptor homodimeric complex(GO:0038038) |
| 0.1 | 0.1 | GO:0097598 | sperm cytoplasmic droplet(GO:0097598) |
| 0.1 | 4.0 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
| 0.1 | 0.9 | GO:0015630 | microtubule cytoskeleton(GO:0015630) |
| 0.1 | 1.0 | GO:0043194 | axon initial segment(GO:0043194) |
| 0.1 | 0.9 | GO:0060199 | clathrin-sculpted glutamate transport vesicle(GO:0060199) clathrin-sculpted glutamate transport vesicle membrane(GO:0060203) |
| 0.1 | 1.2 | GO:0072546 | ER membrane protein complex(GO:0072546) |
| 0.1 | 1.0 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
| 0.1 | 1.8 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
| 0.1 | 2.4 | GO:0032585 | multivesicular body membrane(GO:0032585) |
| 0.1 | 1.2 | GO:0001673 | male germ cell nucleus(GO:0001673) |
| 0.1 | 0.9 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
| 0.1 | 0.3 | GO:1990742 | microvesicle(GO:1990742) |
| 0.1 | 0.6 | GO:0097449 | astrocyte projection(GO:0097449) |
| 0.1 | 1.3 | GO:0045180 | basal cortex(GO:0045180) |
| 0.1 | 2.9 | GO:0030016 | myofibril(GO:0030016) |
| 0.1 | 10.7 | GO:0005884 | actin filament(GO:0005884) |
| 0.1 | 2.1 | GO:0044295 | axonal growth cone(GO:0044295) |
| 0.1 | 1.2 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
| 0.1 | 5.5 | GO:0005604 | basement membrane(GO:0005604) |
| 0.1 | 0.7 | GO:0070069 | cytochrome complex(GO:0070069) |
| 0.1 | 1.5 | GO:0035371 | microtubule plus-end(GO:0035371) |
| 0.1 | 2.7 | GO:0030286 | dynein complex(GO:0030286) |
| 0.1 | 0.2 | GO:0072534 | perineuronal net(GO:0072534) |
| 0.1 | 6.3 | GO:0005581 | collagen trimer(GO:0005581) |
| 0.1 | 0.5 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
| 0.1 | 2.1 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
| 0.1 | 0.9 | GO:0032039 | integrator complex(GO:0032039) |
| 0.1 | 0.5 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
| 0.1 | 0.2 | GO:0031213 | RSF complex(GO:0031213) |
| 0.1 | 0.3 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
| 0.1 | 0.8 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
| 0.1 | 0.9 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
| 0.1 | 0.3 | GO:0031417 | NatC complex(GO:0031417) |
| 0.1 | 1.3 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
| 0.1 | 0.3 | GO:0000333 | telomerase catalytic core complex(GO:0000333) |
| 0.1 | 1.4 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
| 0.0 | 5.9 | GO:0005811 | lipid particle(GO:0005811) |
| 0.0 | 0.1 | GO:0042565 | RNA nuclear export complex(GO:0042565) |
| 0.0 | 12.8 | GO:0043209 | myelin sheath(GO:0043209) |
| 0.0 | 6.5 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
| 0.0 | 4.6 | GO:0005901 | caveola(GO:0005901) |
| 0.0 | 2.9 | GO:0048786 | presynaptic active zone(GO:0048786) |
| 0.0 | 2.8 | GO:0043198 | dendritic shaft(GO:0043198) |
| 0.0 | 1.5 | GO:0042641 | actomyosin(GO:0042641) |
| 0.0 | 1.7 | GO:0030057 | desmosome(GO:0030057) |
| 0.0 | 0.4 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
| 0.0 | 4.6 | GO:0001669 | acrosomal vesicle(GO:0001669) |
| 0.0 | 0.5 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
| 0.0 | 0.7 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
| 0.0 | 1.9 | GO:0031901 | early endosome membrane(GO:0031901) |
| 0.0 | 3.3 | GO:0097014 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
| 0.0 | 0.6 | GO:0043231 | intracellular membrane-bounded organelle(GO:0043231) |
| 0.0 | 0.2 | GO:0097440 | apical dendrite(GO:0097440) |
| 0.0 | 8.0 | GO:0031225 | anchored component of membrane(GO:0031225) |
| 0.0 | 0.2 | GO:0005879 | axonemal microtubule(GO:0005879) |
| 0.0 | 19.8 | GO:0031012 | extracellular matrix(GO:0031012) |
| 0.0 | 0.8 | GO:0034706 | sodium channel complex(GO:0034706) |
| 0.0 | 0.4 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
| 0.0 | 0.6 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
| 0.0 | 1.4 | GO:0042629 | mast cell granule(GO:0042629) |
| 0.0 | 0.1 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
| 0.0 | 4.9 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
| 0.0 | 0.4 | GO:0046581 | intercellular canaliculus(GO:0046581) |
| 0.0 | 1.7 | GO:0032420 | stereocilium(GO:0032420) |
| 0.0 | 1.0 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
| 0.0 | 4.3 | GO:0043204 | perikaryon(GO:0043204) |
| 0.0 | 0.3 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
| 0.0 | 0.5 | GO:0001520 | outer dense fiber(GO:0001520) |
| 0.0 | 0.2 | GO:0009925 | basal plasma membrane(GO:0009925) |
| 0.0 | 1.7 | GO:1904115 | axon cytoplasm(GO:1904115) |
| 0.0 | 2.4 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
| 0.0 | 1.7 | GO:0016328 | lateral plasma membrane(GO:0016328) |
| 0.0 | 0.4 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
| 0.0 | 0.2 | GO:0001405 | presequence translocase-associated import motor(GO:0001405) |
| 0.0 | 0.3 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
| 0.0 | 0.2 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
| 0.0 | 1.3 | GO:0001533 | cornified envelope(GO:0001533) |
| 0.0 | 0.3 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
| 0.0 | 0.5 | GO:0031209 | SCAR complex(GO:0031209) |
| 0.0 | 0.2 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
| 0.0 | 0.1 | GO:0097125 | cyclin B1-CDK1 complex(GO:0097125) |
| 0.0 | 0.6 | GO:0005686 | U2 snRNP(GO:0005686) |
| 0.0 | 0.2 | GO:0042405 | nuclear inclusion body(GO:0042405) |
| 0.0 | 0.4 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
| 0.0 | 0.1 | GO:1990393 | 3M complex(GO:1990393) |
| 0.0 | 0.5 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
| 0.0 | 0.2 | GO:0005577 | fibrinogen complex(GO:0005577) |
| 0.0 | 1.7 | GO:1904724 | tertiary granule lumen(GO:1904724) |
| 0.0 | 0.5 | GO:0030127 | COPII vesicle coat(GO:0030127) |
| 0.0 | 0.1 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
| 0.0 | 0.8 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
| 0.0 | 4.6 | GO:0001650 | fibrillar center(GO:0001650) |
| 0.0 | 0.4 | GO:0036038 | MKS complex(GO:0036038) |
| 0.0 | 1.6 | GO:0042734 | presynaptic membrane(GO:0042734) |
| 0.0 | 2.6 | GO:0031968 | organelle outer membrane(GO:0031968) |
| 0.0 | 0.5 | GO:0097546 | ciliary base(GO:0097546) |
| 0.0 | 0.6 | GO:0005771 | multivesicular body(GO:0005771) |
| 0.0 | 0.4 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
| 0.0 | 0.1 | GO:0043073 | germ cell nucleus(GO:0043073) |
| 0.0 | 0.1 | GO:0097431 | mitotic spindle pole(GO:0097431) |
| 0.0 | 0.4 | GO:0005719 | nuclear euchromatin(GO:0005719) |
| 0.0 | 0.1 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
| 0.0 | 0.3 | GO:0070469 | respiratory chain(GO:0070469) |
| 0.0 | 1.4 | GO:0005776 | autophagosome(GO:0005776) |
| 0.0 | 0.2 | GO:0042555 | MCM complex(GO:0042555) |
| 0.0 | 0.8 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
| 0.0 | 7.5 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
| 0.0 | 0.7 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
| 0.0 | 0.3 | GO:0030008 | TRAPP complex(GO:0030008) |
| 0.0 | 0.2 | GO:0042587 | glycogen granule(GO:0042587) |
| 0.0 | 0.2 | GO:0000243 | commitment complex(GO:0000243) |
| 0.0 | 1.4 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
| 0.0 | 0.2 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
| 0.0 | 0.2 | GO:0061695 | transferase complex, transferring phosphorus-containing groups(GO:0061695) |
| 0.0 | 0.4 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
| 0.0 | 0.2 | GO:0033178 | proton-transporting two-sector ATPase complex, catalytic domain(GO:0033178) |
| 0.0 | 0.3 | GO:0001741 | XY body(GO:0001741) |
| 0.0 | 0.3 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
| 0.0 | 0.5 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
| 0.0 | 0.2 | GO:0030914 | STAGA complex(GO:0030914) |
| 0.0 | 0.7 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
| 0.0 | 0.2 | GO:0031258 | lamellipodium membrane(GO:0031258) |
Gene overrepresentation in molecular_function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.3 | 3.9 | GO:0008892 | guanine deaminase activity(GO:0008892) |
| 1.1 | 3.4 | GO:0005298 | proline:sodium symporter activity(GO:0005298) |
| 1.0 | 4.8 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
| 0.9 | 3.8 | GO:0035939 | microsatellite binding(GO:0035939) |
| 0.9 | 3.7 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
| 0.9 | 2.7 | GO:0048244 | phytanoyl-CoA dioxygenase activity(GO:0048244) |
| 0.8 | 4.2 | GO:0015254 | glycerol channel activity(GO:0015254) |
| 0.8 | 2.5 | GO:0004019 | adenylosuccinate synthase activity(GO:0004019) |
| 0.8 | 7.3 | GO:0043237 | laminin-1 binding(GO:0043237) |
| 0.8 | 4.0 | GO:0070576 | vitamin D 24-hydroxylase activity(GO:0070576) |
| 0.8 | 2.4 | GO:0015168 | glycerol transmembrane transporter activity(GO:0015168) |
| 0.8 | 2.4 | GO:0035248 | alpha-1,4-N-acetylgalactosaminyltransferase activity(GO:0035248) |
| 0.8 | 3.8 | GO:0052836 | inositol 5-diphosphate pentakisphosphate 5-kinase activity(GO:0052836) inositol diphosphate tetrakisphosphate kinase activity(GO:0052839) |
| 0.7 | 2.2 | GO:0051538 | 3 iron, 4 sulfur cluster binding(GO:0051538) |
| 0.7 | 2.9 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
| 0.7 | 2.1 | GO:0070320 | inward rectifier potassium channel inhibitor activity(GO:0070320) |
| 0.7 | 4.9 | GO:0052739 | phosphatidylserine 1-acylhydrolase activity(GO:0052739) |
| 0.7 | 2.0 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
| 0.6 | 4.4 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
| 0.6 | 1.8 | GO:0050840 | extracellular matrix binding(GO:0050840) |
| 0.6 | 9.1 | GO:0070324 | thyroid hormone binding(GO:0070324) |
| 0.6 | 13.8 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
| 0.6 | 2.3 | GO:0047860 | diiodophenylpyruvate reductase activity(GO:0047860) |
| 0.5 | 2.1 | GO:0004040 | amidase activity(GO:0004040) |
| 0.5 | 1.1 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
| 0.5 | 3.1 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
| 0.5 | 2.0 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
| 0.5 | 1.5 | GO:0052857 | NADHX epimerase activity(GO:0052856) NADPHX epimerase activity(GO:0052857) |
| 0.5 | 2.0 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
| 0.5 | 5.1 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
| 0.5 | 2.0 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
| 0.5 | 3.0 | GO:0003989 | acetyl-CoA carboxylase activity(GO:0003989) |
| 0.5 | 2.0 | GO:0004923 | leukemia inhibitory factor receptor activity(GO:0004923) |
| 0.5 | 1.9 | GO:0008112 | nicotinamide N-methyltransferase activity(GO:0008112) pyridine N-methyltransferase activity(GO:0030760) |
| 0.5 | 2.4 | GO:0004775 | succinate-CoA ligase (ADP-forming) activity(GO:0004775) |
| 0.5 | 6.2 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
| 0.5 | 1.9 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
| 0.5 | 2.8 | GO:0019828 | aspartic-type endopeptidase inhibitor activity(GO:0019828) |
| 0.5 | 1.4 | GO:0015130 | mevalonate transmembrane transporter activity(GO:0015130) |
| 0.4 | 13.4 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
| 0.4 | 1.3 | GO:0003955 | NAD(P)H dehydrogenase (quinone) activity(GO:0003955) |
| 0.4 | 5.4 | GO:0030274 | LIM domain binding(GO:0030274) |
| 0.4 | 3.3 | GO:0019959 | interleukin-8 binding(GO:0019959) |
| 0.4 | 3.3 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
| 0.4 | 1.6 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
| 0.4 | 3.2 | GO:0098821 | BMP receptor activity(GO:0098821) |
| 0.4 | 1.2 | GO:0072510 | ferric iron transmembrane transporter activity(GO:0015091) trivalent inorganic cation transmembrane transporter activity(GO:0072510) |
| 0.4 | 3.1 | GO:0004118 | cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) |
| 0.4 | 8.8 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
| 0.4 | 3.4 | GO:0019798 | procollagen-proline 4-dioxygenase activity(GO:0004656) procollagen-proline dioxygenase activity(GO:0019798) |
| 0.4 | 3.7 | GO:0004111 | creatine kinase activity(GO:0004111) |
| 0.4 | 0.7 | GO:0051213 | dioxygenase activity(GO:0051213) |
| 0.4 | 5.2 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
| 0.4 | 16.1 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
| 0.4 | 1.5 | GO:0086062 | voltage-gated sodium channel activity involved in Purkinje myocyte action potential(GO:0086062) |
| 0.4 | 2.9 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
| 0.4 | 3.2 | GO:0030023 | extracellular matrix constituent conferring elasticity(GO:0030023) |
| 0.3 | 1.0 | GO:0004958 | prostaglandin F receptor activity(GO:0004958) |
| 0.3 | 2.4 | GO:0004471 | malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) malate dehydrogenase (decarboxylating) (NADP+) activity(GO:0004473) |
| 0.3 | 1.7 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
| 0.3 | 4.0 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
| 0.3 | 1.0 | GO:0016649 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
| 0.3 | 1.3 | GO:1990175 | EH domain binding(GO:1990175) |
| 0.3 | 4.2 | GO:0019215 | intermediate filament binding(GO:0019215) |
| 0.3 | 1.3 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
| 0.3 | 1.6 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
| 0.3 | 3.2 | GO:0005497 | androgen binding(GO:0005497) |
| 0.3 | 1.3 | GO:0072590 | N-acetyl-L-aspartate-L-glutamate ligase activity(GO:0072590) |
| 0.3 | 1.3 | GO:0017095 | heparan sulfate 6-O-sulfotransferase activity(GO:0017095) |
| 0.3 | 3.1 | GO:0016015 | morphogen activity(GO:0016015) |
| 0.3 | 2.5 | GO:0008241 | peptidyl-dipeptidase activity(GO:0008241) |
| 0.3 | 2.6 | GO:1904929 | coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway(GO:1904929) |
| 0.3 | 0.9 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
| 0.3 | 8.9 | GO:0031005 | filamin binding(GO:0031005) |
| 0.3 | 0.8 | GO:0050613 | delta14-sterol reductase activity(GO:0050613) |
| 0.3 | 2.4 | GO:0016627 | oxidoreductase activity, acting on the CH-CH group of donors(GO:0016627) |
| 0.3 | 0.8 | GO:0004597 | peptide-aspartate beta-dioxygenase activity(GO:0004597) |
| 0.3 | 1.3 | GO:0070052 | collagen V binding(GO:0070052) |
| 0.3 | 4.2 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
| 0.3 | 1.1 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
| 0.3 | 2.1 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
| 0.3 | 1.0 | GO:0038132 | neuregulin binding(GO:0038132) |
| 0.3 | 4.0 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
| 0.2 | 2.2 | GO:0050692 | DBD domain binding(GO:0050692) |
| 0.2 | 0.7 | GO:0031731 | CCR6 chemokine receptor binding(GO:0031731) |
| 0.2 | 8.5 | GO:0015002 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
| 0.2 | 5.5 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
| 0.2 | 0.7 | GO:0047536 | 2-aminoadipate transaminase activity(GO:0047536) |
| 0.2 | 0.7 | GO:0010309 | acireductone dioxygenase [iron(II)-requiring] activity(GO:0010309) |
| 0.2 | 6.7 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
| 0.2 | 1.1 | GO:0003947 | (N-acetylneuraminyl)-galactosylglucosylceramide N-acetylgalactosaminyltransferase activity(GO:0003947) |
| 0.2 | 5.7 | GO:0031432 | titin binding(GO:0031432) |
| 0.2 | 2.7 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
| 0.2 | 0.9 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
| 0.2 | 0.9 | GO:0005350 | pyrimidine nucleobase transmembrane transporter activity(GO:0005350) pyrimidine- and adenine-specific:sodium symporter activity(GO:0015389) |
| 0.2 | 2.2 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
| 0.2 | 5.1 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
| 0.2 | 2.1 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
| 0.2 | 0.6 | GO:0031071 | cysteine desulfurase activity(GO:0031071) |
| 0.2 | 29.1 | GO:0005518 | collagen binding(GO:0005518) |
| 0.2 | 1.0 | GO:0004782 | sulfinoalanine decarboxylase activity(GO:0004782) |
| 0.2 | 1.0 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
| 0.2 | 0.8 | GO:0005260 | channel-conductance-controlling ATPase activity(GO:0005260) |
| 0.2 | 1.4 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
| 0.2 | 2.2 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
| 0.2 | 1.8 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
| 0.2 | 1.6 | GO:0008121 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
| 0.2 | 0.8 | GO:0030172 | troponin C binding(GO:0030172) |
| 0.2 | 1.0 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
| 0.2 | 0.8 | GO:0004047 | aminomethyltransferase activity(GO:0004047) |
| 0.2 | 0.8 | GO:0004967 | glucagon receptor activity(GO:0004967) |
| 0.2 | 0.4 | GO:0003680 | AT DNA binding(GO:0003680) |
| 0.2 | 0.6 | GO:0016418 | S-acetyltransferase activity(GO:0016418) |
| 0.2 | 0.6 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
| 0.2 | 8.4 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
| 0.2 | 3.6 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
| 0.2 | 0.6 | GO:0015439 | heme-transporting ATPase activity(GO:0015439) |
| 0.2 | 1.2 | GO:0008048 | calcium sensitive guanylate cyclase activator activity(GO:0008048) |
| 0.2 | 1.2 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
| 0.2 | 3.4 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
| 0.2 | 1.3 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
| 0.2 | 1.3 | GO:0050682 | AF-2 domain binding(GO:0050682) |
| 0.2 | 1.2 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
| 0.2 | 0.5 | GO:0045155 | electron transporter, transferring electrons from CoQH2-cytochrome c reductase complex and cytochrome c oxidase complex activity(GO:0045155) |
| 0.2 | 1.0 | GO:0070699 | type II activin receptor binding(GO:0070699) |
| 0.2 | 1.0 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
| 0.2 | 0.6 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
| 0.2 | 0.5 | GO:0015117 | thiosulfate transmembrane transporter activity(GO:0015117) oxaloacetate transmembrane transporter activity(GO:0015131) |
| 0.2 | 2.6 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
| 0.2 | 3.7 | GO:0070330 | aromatase activity(GO:0070330) |
| 0.2 | 1.5 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
| 0.2 | 0.8 | GO:0004329 | formate-tetrahydrofolate ligase activity(GO:0004329) |
| 0.2 | 0.8 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
| 0.2 | 2.0 | GO:0032051 | clathrin light chain binding(GO:0032051) |
| 0.2 | 2.4 | GO:0045159 | myosin II binding(GO:0045159) |
| 0.2 | 2.6 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
| 0.2 | 0.5 | GO:0015361 | low-affinity sodium:dicarboxylate symporter activity(GO:0015361) |
| 0.2 | 0.5 | GO:0033149 | FFAT motif binding(GO:0033149) |
| 0.2 | 3.0 | GO:0004017 | adenylate kinase activity(GO:0004017) |
| 0.2 | 9.5 | GO:0008137 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
| 0.1 | 1.3 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
| 0.1 | 1.3 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
| 0.1 | 1.2 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
| 0.1 | 0.7 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
| 0.1 | 10.1 | GO:0008307 | structural constituent of muscle(GO:0008307) |
| 0.1 | 6.3 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
| 0.1 | 6.8 | GO:0001972 | retinoic acid binding(GO:0001972) |
| 0.1 | 15.8 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
| 0.1 | 7.2 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
| 0.1 | 1.0 | GO:0003993 | acid phosphatase activity(GO:0003993) |
| 0.1 | 1.8 | GO:0051525 | NFAT protein binding(GO:0051525) |
| 0.1 | 1.1 | GO:1904288 | BAT3 complex binding(GO:1904288) |
| 0.1 | 1.0 | GO:0047288 | monosialoganglioside sialyltransferase activity(GO:0047288) |
| 0.1 | 0.5 | GO:0051431 | corticotropin-releasing hormone receptor binding(GO:0051429) corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
| 0.1 | 0.8 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
| 0.1 | 0.8 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
| 0.1 | 2.7 | GO:0051393 | alpha-actinin binding(GO:0051393) |
| 0.1 | 1.5 | GO:0019237 | centromeric DNA binding(GO:0019237) |
| 0.1 | 0.4 | GO:0070984 | SET domain binding(GO:0070984) |
| 0.1 | 3.4 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
| 0.1 | 0.8 | GO:0032190 | acrosin binding(GO:0032190) |
| 0.1 | 0.5 | GO:0071885 | N-terminal protein N-methyltransferase activity(GO:0071885) |
| 0.1 | 0.9 | GO:0061575 | cyclin-dependent protein serine/threonine kinase activator activity(GO:0061575) |
| 0.1 | 1.8 | GO:0032027 | myosin light chain binding(GO:0032027) |
| 0.1 | 2.1 | GO:0099602 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
| 0.1 | 0.9 | GO:0004447 | iodide peroxidase activity(GO:0004447) |
| 0.1 | 2.2 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
| 0.1 | 0.5 | GO:0047708 | biotinidase activity(GO:0047708) |
| 0.1 | 0.5 | GO:0031013 | troponin I binding(GO:0031013) |
| 0.1 | 1.0 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) O-palmitoyltransferase activity(GO:0016416) |
| 0.1 | 1.5 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
| 0.1 | 0.7 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
| 0.1 | 0.5 | GO:0005026 | transforming growth factor beta receptor activity, type II(GO:0005026) |
| 0.1 | 1.7 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
| 0.1 | 0.8 | GO:0004909 | interleukin-1, Type I, activating receptor activity(GO:0004909) |
| 0.1 | 0.9 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
| 0.1 | 1.0 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
| 0.1 | 17.1 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
| 0.1 | 0.7 | GO:0032089 | NACHT domain binding(GO:0032089) |
| 0.1 | 0.9 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
| 0.1 | 0.6 | GO:0008798 | beta-aspartyl-peptidase activity(GO:0008798) |
| 0.1 | 0.5 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
| 0.1 | 3.3 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
| 0.1 | 0.4 | GO:1990404 | protein ADP-ribosylase activity(GO:1990404) |
| 0.1 | 1.0 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
| 0.1 | 2.4 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
| 0.1 | 2.0 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
| 0.1 | 0.3 | GO:0016532 | superoxide dismutase copper chaperone activity(GO:0016532) |
| 0.1 | 2.5 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
| 0.1 | 2.5 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
| 0.1 | 0.4 | GO:0008391 | arachidonic acid monooxygenase activity(GO:0008391) arachidonic acid epoxygenase activity(GO:0008392) |
| 0.1 | 2.2 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
| 0.1 | 0.2 | GO:0010465 | nerve growth factor receptor activity(GO:0010465) |
| 0.1 | 0.9 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
| 0.1 | 0.9 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
| 0.1 | 0.8 | GO:0004771 | sterol esterase activity(GO:0004771) |
| 0.1 | 0.2 | GO:0015140 | malate transmembrane transporter activity(GO:0015140) |
| 0.1 | 0.7 | GO:0008823 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
| 0.1 | 0.7 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
| 0.1 | 3.0 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
| 0.1 | 0.8 | GO:0016835 | carbon-oxygen lyase activity(GO:0016835) |
| 0.1 | 2.0 | GO:0005248 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
| 0.1 | 0.5 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
| 0.1 | 0.4 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) |
| 0.1 | 0.4 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
| 0.1 | 3.2 | GO:0003746 | translation elongation factor activity(GO:0003746) |
| 0.1 | 2.3 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
| 0.1 | 0.3 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
| 0.1 | 0.9 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
| 0.1 | 1.9 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
| 0.1 | 0.7 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
| 0.1 | 0.6 | GO:0043532 | angiostatin binding(GO:0043532) |
| 0.1 | 0.3 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
| 0.1 | 0.2 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
| 0.1 | 1.1 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
| 0.1 | 1.5 | GO:0043236 | laminin binding(GO:0043236) |
| 0.1 | 0.5 | GO:0015184 | L-cystine transmembrane transporter activity(GO:0015184) |
| 0.1 | 1.3 | GO:0048019 | receptor antagonist activity(GO:0048019) |
| 0.1 | 0.3 | GO:0004802 | transketolase activity(GO:0004802) |
| 0.1 | 0.5 | GO:0050436 | microfibril binding(GO:0050436) |
| 0.1 | 0.2 | GO:0031877 | somatostatin receptor binding(GO:0031877) |
| 0.1 | 0.9 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
| 0.1 | 0.3 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
| 0.1 | 4.2 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
| 0.1 | 0.4 | GO:0030060 | L-malate dehydrogenase activity(GO:0030060) |
| 0.1 | 1.3 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
| 0.1 | 0.9 | GO:0001968 | fibronectin binding(GO:0001968) |
| 0.1 | 0.6 | GO:0033857 | diphosphoinositol-pentakisphosphate kinase activity(GO:0033857) |
| 0.1 | 2.4 | GO:0071837 | HMG box domain binding(GO:0071837) |
| 0.1 | 0.3 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
| 0.1 | 0.4 | GO:0032452 | histone demethylase activity(GO:0032452) |
| 0.1 | 0.9 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
| 0.1 | 5.0 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
| 0.1 | 1.2 | GO:0000146 | microfilament motor activity(GO:0000146) |
| 0.1 | 1.5 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
| 0.1 | 0.3 | GO:0061628 | H3K27me3 modified histone binding(GO:0061628) |
| 0.1 | 0.6 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) |
| 0.1 | 0.5 | GO:0035243 | protein-arginine omega-N symmetric methyltransferase activity(GO:0035243) |
| 0.1 | 0.5 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
| 0.1 | 0.3 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
| 0.1 | 9.8 | GO:0051117 | ATPase binding(GO:0051117) |
| 0.1 | 1.9 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
| 0.1 | 0.3 | GO:0008665 | 2'-phosphotransferase activity(GO:0008665) |
| 0.1 | 1.2 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
| 0.1 | 0.4 | GO:0019966 | interleukin-1 binding(GO:0019966) |
| 0.1 | 0.3 | GO:0005334 | norepinephrine:sodium symporter activity(GO:0005334) |
| 0.1 | 1.3 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
| 0.1 | 0.7 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
| 0.1 | 0.5 | GO:0005113 | patched binding(GO:0005113) |
| 0.1 | 1.2 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
| 0.1 | 1.2 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
| 0.1 | 0.4 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
| 0.1 | 0.4 | GO:0000179 | rRNA (adenine-N6,N6-)-dimethyltransferase activity(GO:0000179) |
| 0.1 | 5.4 | GO:0005044 | scavenger receptor activity(GO:0005044) |
| 0.1 | 1.8 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
| 0.1 | 1.0 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
| 0.1 | 1.1 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
| 0.1 | 1.1 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
| 0.1 | 0.8 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
| 0.1 | 0.8 | GO:0089720 | caspase binding(GO:0089720) |
| 0.1 | 0.8 | GO:0004969 | histamine receptor activity(GO:0004969) |
| 0.1 | 0.3 | GO:0031728 | CCR3 chemokine receptor binding(GO:0031728) |
| 0.1 | 1.6 | GO:0008527 | taste receptor activity(GO:0008527) |
| 0.1 | 2.0 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
| 0.1 | 0.4 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
| 0.1 | 0.7 | GO:0042731 | PH domain binding(GO:0042731) |
| 0.1 | 1.0 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
| 0.1 | 3.3 | GO:0030371 | translation repressor activity(GO:0030371) |
| 0.1 | 1.0 | GO:0000977 | RNA polymerase II regulatory region sequence-specific DNA binding(GO:0000977) RNA polymerase II regulatory region DNA binding(GO:0001012) |
| 0.1 | 1.4 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
| 0.1 | 0.2 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
| 0.1 | 1.7 | GO:0042043 | neurexin family protein binding(GO:0042043) |
| 0.1 | 2.3 | GO:0005158 | insulin receptor binding(GO:0005158) |
| 0.1 | 0.3 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
| 0.1 | 1.7 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
| 0.1 | 0.6 | GO:0017166 | vinculin binding(GO:0017166) |
| 0.1 | 1.0 | GO:0048018 | receptor agonist activity(GO:0048018) |
| 0.1 | 0.9 | GO:0033691 | sialic acid binding(GO:0033691) |
| 0.1 | 1.0 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
| 0.1 | 0.8 | GO:0070700 | BMP receptor binding(GO:0070700) |
| 0.1 | 4.3 | GO:0098531 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) transcription factor activity, direct ligand regulated sequence-specific DNA binding(GO:0098531) |
| 0.1 | 0.8 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
| 0.1 | 0.3 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
| 0.1 | 0.5 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
| 0.1 | 0.6 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
| 0.1 | 0.3 | GO:0071253 | connexin binding(GO:0071253) |
| 0.1 | 2.5 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
| 0.1 | 0.2 | GO:0017129 | triglyceride binding(GO:0017129) |
| 0.1 | 0.7 | GO:0019841 | retinol binding(GO:0019841) |
| 0.1 | 0.3 | GO:0003998 | acylphosphatase activity(GO:0003998) |
| 0.0 | 0.1 | GO:0047225 | acetylgalactosaminyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0047225) |
| 0.0 | 0.4 | GO:0060072 | large conductance calcium-activated potassium channel activity(GO:0060072) |
| 0.0 | 0.6 | GO:0045499 | chemorepellent activity(GO:0045499) |
| 0.0 | 2.0 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
| 0.0 | 8.1 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
| 0.0 | 4.7 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
| 0.0 | 0.2 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
| 0.0 | 0.3 | GO:0034604 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
| 0.0 | 1.2 | GO:0001848 | complement binding(GO:0001848) |
| 0.0 | 0.2 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
| 0.0 | 6.0 | GO:0005267 | potassium channel activity(GO:0005267) |
| 0.0 | 11.1 | GO:0051015 | actin filament binding(GO:0051015) |
| 0.0 | 0.6 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
| 0.0 | 0.9 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
| 0.0 | 0.7 | GO:0035497 | cAMP response element binding(GO:0035497) |
| 0.0 | 0.8 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) |
| 0.0 | 0.7 | GO:0005542 | folic acid binding(GO:0005542) |
| 0.0 | 0.2 | GO:0004419 | hydroxymethylglutaryl-CoA lyase activity(GO:0004419) |
| 0.0 | 1.0 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
| 0.0 | 0.3 | GO:0016723 | oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor(GO:0016723) |
| 0.0 | 5.4 | GO:0005178 | integrin binding(GO:0005178) |
| 0.0 | 0.8 | GO:0005003 | ephrin receptor activity(GO:0005003) |
| 0.0 | 0.2 | GO:0052810 | 1-phosphatidylinositol-5-kinase activity(GO:0052810) |
| 0.0 | 1.1 | GO:0070001 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
| 0.0 | 0.6 | GO:0098960 | postsynaptic neurotransmitter receptor activity(GO:0098960) |
| 0.0 | 5.3 | GO:0008201 | heparin binding(GO:0008201) |
| 0.0 | 2.5 | GO:0019838 | growth factor binding(GO:0019838) |
| 0.0 | 0.7 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
| 0.0 | 0.1 | GO:0071566 | UFM1 activating enzyme activity(GO:0071566) |
| 0.0 | 0.4 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
| 0.0 | 1.7 | GO:0005549 | odorant binding(GO:0005549) |
| 0.0 | 1.4 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
| 0.0 | 0.6 | GO:0005243 | gap junction channel activity(GO:0005243) |
| 0.0 | 1.4 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
| 0.0 | 0.9 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
| 0.0 | 0.3 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
| 0.0 | 0.2 | GO:0004441 | inositol-1,4-bisphosphate 1-phosphatase activity(GO:0004441) inositol-1,3,4-trisphosphate 1-phosphatase activity(GO:0052829) |
| 0.0 | 0.2 | GO:0004966 | galanin receptor activity(GO:0004966) |
| 0.0 | 0.3 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
| 0.0 | 0.2 | GO:0003983 | UTP:glucose-1-phosphate uridylyltransferase activity(GO:0003983) UTP-monosaccharide-1-phosphate uridylyltransferase activity(GO:0051748) |
| 0.0 | 0.4 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
| 0.0 | 1.7 | GO:0004385 | guanylate kinase activity(GO:0004385) |
| 0.0 | 0.1 | GO:0008431 | vitamin E binding(GO:0008431) |
| 0.0 | 0.2 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
| 0.0 | 0.9 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
| 0.0 | 4.1 | GO:0019888 | protein phosphatase regulator activity(GO:0019888) |
| 0.0 | 0.3 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
| 0.0 | 0.6 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
| 0.0 | 0.4 | GO:0070182 | DNA polymerase binding(GO:0070182) |
| 0.0 | 1.3 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
| 0.0 | 0.7 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
| 0.0 | 2.1 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
| 0.0 | 2.0 | GO:0070888 | E-box binding(GO:0070888) |
| 0.0 | 0.6 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
| 0.0 | 0.6 | GO:0002162 | dystroglycan binding(GO:0002162) |
| 0.0 | 0.2 | GO:0031419 | cobalamin binding(GO:0031419) |
| 0.0 | 0.2 | GO:0034185 | apolipoprotein binding(GO:0034185) |
| 0.0 | 0.6 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
| 0.0 | 0.6 | GO:0044213 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
| 0.0 | 0.1 | GO:0003870 | 5-aminolevulinate synthase activity(GO:0003870) N-succinyltransferase activity(GO:0016749) |
| 0.0 | 1.2 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
| 0.0 | 0.6 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
| 0.0 | 0.4 | GO:0032041 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
| 0.0 | 0.3 | GO:1990446 | U1 snRNP binding(GO:1990446) |
| 0.0 | 0.4 | GO:0070064 | proline-rich region binding(GO:0070064) |
| 0.0 | 1.5 | GO:0097110 | scaffold protein binding(GO:0097110) |
| 0.0 | 1.3 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
| 0.0 | 0.3 | GO:0005280 | hydrogen:amino acid symporter activity(GO:0005280) |
| 0.0 | 0.8 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
| 0.0 | 0.3 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
| 0.0 | 0.0 | GO:0008177 | succinate dehydrogenase (ubiquinone) activity(GO:0008177) |
| 0.0 | 0.3 | GO:0042805 | actinin binding(GO:0042805) |
| 0.0 | 0.2 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
| 0.0 | 0.8 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
| 0.0 | 0.0 | GO:0015185 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
| 0.0 | 0.5 | GO:0001190 | transcriptional activator activity, RNA polymerase II transcription factor binding(GO:0001190) transcriptional repressor activity, RNA polymerase II activating transcription factor binding(GO:0098811) |
| 0.0 | 0.6 | GO:0097602 | cullin family protein binding(GO:0097602) |
| 0.0 | 0.1 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
| 0.0 | 0.6 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
| 0.0 | 0.7 | GO:0030552 | cAMP binding(GO:0030552) |
| 0.0 | 0.4 | GO:0003796 | lysozyme activity(GO:0003796) |
| 0.0 | 2.0 | GO:0043565 | sequence-specific DNA binding(GO:0043565) |
| 0.0 | 0.1 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
| 0.0 | 0.1 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
| 0.0 | 0.1 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
| 0.0 | 0.4 | GO:0043495 | protein anchor(GO:0043495) |
| 0.0 | 0.4 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
| 0.0 | 1.0 | GO:0030332 | cyclin binding(GO:0030332) |
| 0.0 | 6.8 | GO:0003714 | transcription corepressor activity(GO:0003714) |
| 0.0 | 0.1 | GO:0004450 | isocitrate dehydrogenase (NADP+) activity(GO:0004450) |
| 0.0 | 0.6 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
| 0.0 | 0.3 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
| 0.0 | 0.2 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
| 0.0 | 0.3 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
| 0.0 | 0.2 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
| 0.0 | 0.2 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
| 0.0 | 0.3 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
| 0.0 | 0.1 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
| 0.0 | 0.1 | GO:0016638 | oxidoreductase activity, acting on the CH-NH2 group of donors(GO:0016638) |
| 0.0 | 0.3 | GO:0004065 | arylsulfatase activity(GO:0004065) |
| 0.0 | 0.4 | GO:0004896 | cytokine receptor activity(GO:0004896) |
| 0.0 | 0.1 | GO:1902444 | riboflavin binding(GO:1902444) |
| 0.0 | 1.8 | GO:0030414 | peptidase inhibitor activity(GO:0030414) |
| 0.0 | 0.2 | GO:0004952 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) dopamine neurotransmitter receptor activity(GO:0004952) |
| 0.0 | 0.5 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
| 0.0 | 0.7 | GO:0005085 | guanyl-nucleotide exchange factor activity(GO:0005085) |
| 0.0 | 0.2 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
| 0.0 | 0.1 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
| 0.0 | 0.2 | GO:0008432 | JUN kinase binding(GO:0008432) |
| 0.0 | 0.1 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
| 0.0 | 0.7 | GO:0017022 | myosin binding(GO:0017022) |
| 0.0 | 0.5 | GO:0004364 | glutathione transferase activity(GO:0004364) |
| 0.0 | 0.2 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
Gene overrepresentation in curated gene sets: canonical pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.4 | 16.0 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
| 0.4 | 10.8 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
| 0.3 | 17.5 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
| 0.2 | 17.0 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
| 0.2 | 8.5 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
| 0.2 | 6.2 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
| 0.2 | 10.5 | ST ADRENERGIC | Adrenergic Pathway |
| 0.2 | 6.3 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
| 0.2 | 4.7 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
| 0.1 | 1.5 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
| 0.1 | 2.8 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
| 0.1 | 6.0 | NABA COLLAGENS | Genes encoding collagen proteins |
| 0.1 | 7.0 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
| 0.1 | 41.6 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
| 0.1 | 32.6 | NABA CORE MATRISOME | Ensemble of genes encoding core extracellular matrix including ECM glycoproteins, collagens and proteoglycans |
| 0.1 | 0.8 | PID IL3 PATHWAY | IL3-mediated signaling events |
| 0.1 | 4.8 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
| 0.1 | 6.5 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
| 0.1 | 1.5 | PID AURORA A PATHWAY | Aurora A signaling |
| 0.1 | 0.5 | PID ALK2 PATHWAY | ALK2 signaling events |
| 0.1 | 1.2 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
| 0.1 | 1.2 | ST G ALPHA S PATHWAY | G alpha s Pathway |
| 0.1 | 3.4 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
| 0.1 | 2.6 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
| 0.1 | 4.1 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
| 0.1 | 21.5 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
| 0.1 | 1.8 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
| 0.1 | 5.0 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
| 0.1 | 4.6 | PID EPHB FWD PATHWAY | EPHB forward signaling |
| 0.1 | 5.4 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
| 0.1 | 1.5 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
| 0.1 | 1.6 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
| 0.1 | 0.5 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
| 0.1 | 4.2 | PID SHP2 PATHWAY | SHP2 signaling |
| 0.1 | 2.8 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
| 0.1 | 0.9 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
| 0.0 | 2.5 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
| 0.0 | 3.4 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
| 0.0 | 1.1 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
| 0.0 | 1.1 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
| 0.0 | 2.5 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
| 0.0 | 3.2 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
| 0.0 | 3.4 | PID CDC42 PATHWAY | CDC42 signaling events |
| 0.0 | 1.2 | PID ALK1 PATHWAY | ALK1 signaling events |
| 0.0 | 0.9 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
| 0.0 | 1.9 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
| 0.0 | 0.9 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
| 0.0 | 3.5 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
| 0.0 | 0.9 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
| 0.0 | 0.2 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
| 0.0 | 1.5 | PID BMP PATHWAY | BMP receptor signaling |
| 0.0 | 0.8 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
| 0.0 | 1.9 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
| 0.0 | 0.5 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
| 0.0 | 0.4 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
| 0.0 | 1.6 | PID ILK PATHWAY | Integrin-linked kinase signaling |
| 0.0 | 0.0 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
| 0.0 | 0.8 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
| 0.0 | 0.2 | ST G ALPHA I PATHWAY | G alpha i Pathway |
| 0.0 | 0.3 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
| 0.0 | 0.4 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
| 0.0 | 0.7 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
| 0.0 | 0.6 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
| 0.0 | 0.4 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
| 0.0 | 0.1 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
Gene overrepresentation in curated gene sets: REACTOME pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.8 | 11.5 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
| 0.7 | 22.0 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
| 0.4 | 6.7 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
| 0.4 | 12.4 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
| 0.3 | 7.4 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
| 0.3 | 0.3 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
| 0.3 | 4.8 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
| 0.3 | 6.2 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
| 0.2 | 15.7 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
| 0.2 | 1.8 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
| 0.2 | 5.4 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
| 0.2 | 8.5 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
| 0.2 | 16.6 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
| 0.2 | 3.2 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
| 0.2 | 0.8 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
| 0.2 | 3.5 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
| 0.2 | 3.3 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
| 0.2 | 4.1 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
| 0.2 | 7.0 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
| 0.2 | 3.3 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
| 0.2 | 1.1 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
| 0.2 | 11.8 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
| 0.2 | 4.1 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
| 0.1 | 1.0 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
| 0.1 | 3.6 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
| 0.1 | 4.2 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
| 0.1 | 4.0 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
| 0.1 | 2.7 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
| 0.1 | 2.0 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
| 0.1 | 2.6 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
| 0.1 | 6.0 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
| 0.1 | 4.3 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
| 0.1 | 4.2 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
| 0.1 | 11.6 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
| 0.1 | 6.0 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
| 0.1 | 2.8 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
| 0.1 | 2.9 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
| 0.1 | 3.9 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
| 0.1 | 2.5 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
| 0.1 | 9.3 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
| 0.1 | 3.0 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
| 0.1 | 11.3 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
| 0.1 | 1.2 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
| 0.1 | 1.1 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
| 0.1 | 4.0 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
| 0.1 | 6.8 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
| 0.1 | 3.0 | REACTOME INTEGRATION OF ENERGY METABOLISM | Genes involved in Integration of energy metabolism |
| 0.1 | 0.6 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
| 0.1 | 0.6 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
| 0.1 | 3.5 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
| 0.1 | 2.5 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
| 0.1 | 3.2 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
| 0.1 | 3.5 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
| 0.1 | 1.1 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
| 0.1 | 2.9 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
| 0.1 | 0.7 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
| 0.1 | 0.9 | REACTOME OPSINS | Genes involved in Opsins |
| 0.1 | 2.3 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
| 0.1 | 1.8 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
| 0.1 | 2.9 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
| 0.1 | 1.0 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
| 0.1 | 3.5 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
| 0.1 | 1.3 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
| 0.1 | 2.8 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
| 0.1 | 1.7 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
| 0.1 | 2.3 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
| 0.0 | 1.3 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
| 0.0 | 2.4 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
| 0.0 | 1.9 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
| 0.0 | 1.8 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
| 0.0 | 0.9 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
| 0.0 | 1.7 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
| 0.0 | 0.9 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
| 0.0 | 2.3 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
| 0.0 | 0.7 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
| 0.0 | 0.9 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
| 0.0 | 1.0 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
| 0.0 | 1.0 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
| 0.0 | 0.9 | REACTOME SCFSKP2 MEDIATED DEGRADATION OF P27 P21 | Genes involved in SCF(Skp2)-mediated degradation of p27/p21 |
| 0.0 | 2.0 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
| 0.0 | 0.2 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
| 0.0 | 0.1 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
| 0.0 | 1.5 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
| 0.0 | 0.8 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
| 0.0 | 0.2 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
| 0.0 | 1.5 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
| 0.0 | 3.6 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
| 0.0 | 1.2 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
| 0.0 | 1.0 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
| 0.0 | 3.4 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
| 0.0 | 0.7 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
| 0.0 | 1.8 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
| 0.0 | 4.3 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
| 0.0 | 0.4 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
| 0.0 | 0.5 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
| 0.0 | 1.2 | REACTOME KINESINS | Genes involved in Kinesins |
| 0.0 | 1.5 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
| 0.0 | 0.1 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
| 0.0 | 2.2 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
| 0.0 | 0.2 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
| 0.0 | 0.9 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
| 0.0 | 4.5 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
| 0.0 | 0.3 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
| 0.0 | 0.7 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
| 0.0 | 0.1 | REACTOME CLEAVAGE OF GROWING TRANSCRIPT IN THE TERMINATION REGION | Genes involved in Cleavage of Growing Transcript in the Termination Region |
| 0.0 | 0.2 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
| 0.0 | 1.0 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
| 0.0 | 0.3 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
| 0.0 | 0.5 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
| 0.0 | 0.5 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
| 0.0 | 0.4 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
| 0.0 | 0.5 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
| 0.0 | 0.3 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
| 0.0 | 2.9 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
| 0.0 | 0.3 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
| 0.0 | 0.8 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
| 0.0 | 1.1 | REACTOME BIOLOGICAL OXIDATIONS | Genes involved in Biological oxidations |
| 0.0 | 0.1 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
| 0.0 | 0.5 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
| 0.0 | 0.0 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
| 0.0 | 0.3 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
| 0.0 | 0.5 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
| 0.0 | 0.7 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |